| Animal |
Tissue/Category |
Description |
Name of Cell |
Registry No. |
More Info at JCRB
site |
Note |
|
bovine |
|
| cornea | |
| |
Page Top
| | | |
| |
| bovine |
cornea
|
normal corneal epithelial cell, production of extracellular matrix proteins
| BCE C/D-1b |
JCRB9129
| more |
|
|
bovine |
Page Top
| | | | |
| kidney | |
| |
| |
| bovine |
kidney
|
established from normal kidney
| MDBK (NBL-1) |
IFO50014
| more |
|
| bovine |
kidney
|
established from normal kidney
| MDBK (NBL-1) |
JCRB9028
| more |
|
| bovine |
kidney
|
normal kidney, MDBK derivative, no serum required
| MDBK.P3 |
JCRB0716
| more |
|
| bovine |
kidney
|
useful to assay bovine adenovirus 3
| CKT-1 |
JCRB0008
| more |
|
| bovine |
kidney
|
useful to assay bovine adenovirus 3
| CKT-1 |
IFO50003
| more |
|
|
bovine |
Page Top
| | | | |
| lung | |
| |
| |
| bovine |
lung
|
embryonic trachea
| EBTr (NBL-4) |
JCRB9038
| more |
|
|
bovine |
Page Top
| | | | |
| vascular system | |
| |
| |
| bovine |
vascular system
|
aortic normal endothelial cell, (SMA-positive smooth muscle cells are intermingled.)
| NM-1 |
JCRB0155
| more |
|
| bovine |
vascular system
|
carotid artery normal endothelial cell
| HH |
JCRB0099
| more |
|
| bovine |
vascular system
|
heart normal endothelial cell, FGF-dependent for survival
| FBHE |
IFO50154
| more |
|
| bovine |
vascular system
|
pulmonary artery normal endothelial cell
| CPA |
JCRB9025
| more |
|
| bovine |
vascular system
|
pulmonary artery normal endothelial cell
| CPA |
IFO50272
| more |
*1) |
| bovine |
vascular system
|
pulmonary artery normal endothelial cell
| CPAE |
JCRB9022
| more |
|
|
cat |
Page Top
| | | | |
| kidney | |
| |
| |
| cat |
kidney
|
kidney, BVD antigen negative
| CRFK |
JCRB9035
| more |
|
|
cat |
Page Top
| | | | |
| neural | |
| |
| |
| cat |
neural
|
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses
| PG-4(S+L-) |
JCRB9125
| more |
|
|
chicken |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| chicken |
hemo-lymphocytic
|
avian leukosis virus (ALV)-induced lymphomas
| DT40 |
JCRB9130
| more |
|
|
chicken |
Page Top
| | | | |
| liver | |
| |
| |
| chicken |
liver
|
hepatocelluler carcinoma, diethylnitrosamine induced
| LMH |
JCRB0237
| more |
|
|
chimpanzee |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| chimpanzee |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
| HSP-239 |
JCRB1165
| more |
|
| chimpanzee |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
| HSP-250 |
JCRB1177
| more |
|
|
cotten-top tamarin |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| cotten-top tamarin |
hemo-lymphocytic
|
EBV transformed, release EBV infectious to primates
| B95-8 |
JCRB9123
| more |
|
|
dog |
Page Top
| | | | |
| kidney | |
| |
| |
| dog |
kidney
|
established from normal kidney, susceptible for many viral species
| MDCK (NBL-2) |
IFO50071
| more |
|
| dog |
kidney
|
established from normal kidney, susceptible for many viral species
| MDCK (NBL-2) |
JCRB9029
| more |
|
| dog |
kidney
|
normal kidney, MDCK derivative, no serum required
| MDCK.P3 |
JCRB0717
| more |
|
|
goat |
Page Top
| | | | |
| esophagus | |
| |
| |
| goat |
esophagus
|
esophagus
| Ch 1 Es |
JCRB9037
| more |
|
|
guinea pig |
Page Top
| | | | |
| fetal body | |
| |
| |
| guinea pig |
fetal body
|
fetal carcass, benzo(a)pyrene transformed, diploid
| 104C1 |
JCRB9036
| more |
|
|
guinea pig |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| guinea pig |
hemo-lymphocytic
|
Guinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
| GP-1 |
JCRB1366
| more |
*2) |
| guinea pig |
hemo-lymphocytic
|
leukemic cell, maintainable only by transplantation
| L2C |
IFO50210
| more |
|
|
hamster, Chinese |
Page Top
| | | | |
| lung | |
| |
| |
| hamster, Chinese |
lung
|
6-thioguanine-resistant V79 cell line
| V79-6TG |
JCRB0219
| more |
|
| hamster, Chinese |
lung
|
anchorage-independent mutant of CHL
| AIG |
JCRB1105
| more |
|
| hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
| cs-17-25 |
JCRB1102
| more |
|
| hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
| cs-19-36 |
JCRB1103
| more |
|
| hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
| cs-20-5 |
JCRB1104
| more |
|
| hamster, Chinese |
lung
|
fibroblast
| V79 |
JCRB0603
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-103-3 |
JCRB1096
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-164-2 |
JCRB1097
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-171-1 |
JCRB1098
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-172-3 |
JCRB1099
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-211 |
JCRB1100
| more |
|
| hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
| hs-222-3 |
JCRB1101
| more |
|
| hamster, Chinese |
lung
|
human monomorphic N-acetyltransferase gene introduced CHL cells
| YG10007 |
JCRB0120
| more |
|
| hamster, Chinese |
lung
|
human polymorphic N-acetyltransferase gene transfected CHL cells
| YG10008 |
JCRB0121
| more |
|
| hamster, Chinese |
lung
|
lung, fibroblast, widely used in somatic genetics
| V79 379A |
IFO50082
| more |
|
| hamster, Chinese |
lung
|
normal
| CHL/IU |
JCRB0030
| more |
|
| hamster, Chinese |
lung
|
salmonella O-acetyltransferase gene introduced CHL cells
| YG10003 |
JCRB0119
| more |
|
| hamster, Chinese |
lung
|
V79 derivative, 6-thioguanine-resistant
| TG1 |
JCRB0626
| more |
|
| hamster, Chinese |
lung
|
V79 derivative, HPRT-deficient
| V79 HPRT~ |
JCRB0707
| more |
|
|
hamster, Chinese |
Page Top
| | | | |
| ovary | |
| |
| |
| hamster, Chinese |
ovary
|
androgen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
| AR-EcoScreen |
JCRB1328
| more |
|
| hamster, Chinese |
ovary
|
HPRT-deficient CHO cell line
| CHO/HGPRT |
JCRB0218
| more |
|
| hamster, Chinese |
ovary
|
pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
| CHO(pMAM-HSluc) |
JCRB0136.2
| more |
|
| hamster, Chinese |
ovary
|
pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
| CHO(pMAM-luc) |
JCRB0136.1
| more |
|
| hamster, Chinese |
ovary
|
subclone of CHO (Chainese hamster ovary) cells
| CHO-K1 |
IFO50414
| more |
|
| hamster, Chinese |
ovary
|
subclone of CHO (Chainese hamster ovary) cells
| CHO-K1 |
JCRB9018
| more |
|
|
hamster, Syrian |
Page Top
| | | | |
| embryo | |
| |
| |
| hamster, Syrian |
embryo
|
fetus fibroblast transformed cell
| DSPT200 |
JCRB0217
| more |
|
| hamster, Syrian |
embryo
|
fibroblast, contact-inhibited
| SHOK |
IFO50367
| more |
|
| hamster, Syrian |
embryo
|
NIL subline adapted to serum-free medium
| NIL-SF2 |
IFO50426
| more |
|
| hamster, Syrian |
embryo
|
transformed from hamster fibroblast
| NIL |
IFO50018
| more |
|
|
hamster, Syrian |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| hamster, Syrian |
hemo-lymphocytic
|
Hamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
| HCT-2 |
JCRB1362
| more |
*2) |
| hamster, Syrian |
hemo-lymphocytic
|
macrophage line
| HM-1 |
JCRB1208
| more |
|
|
hamster, Syrian |
Page Top
| | | | |
| kidney | |
| |
| |
| hamster, Syrian |
kidney
|
kidney, subclone of BHK-21
| BHK-21(C-13) |
JCRB9020
| more |
|
|
hamster, Syrian |
Page Top
| | | | |
| lung | |
| |
| |
| hamster, Syrian |
lung
|
lung, new born
| HT100 |
JCRB0221
| more |
|
|
hamster, Syrian |
Page Top
| | | | |
| melanoma | |
| |
| |
| hamster, Syrian |
melanoma
|
melanotic melanoma
| RPMI 1846 |
JCRB9087
| more |
|
|
human chromosome-introduced |
Page Top
| | | | |
| human chromosomal hybrid | |
| |
| |
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome # 1
| A9(An4)-2 |
JCRB0727
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome # 7
| A9(NTI8)-2 |
JCRB0726
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 11pter>11q23::Xq26>Xqter
| A9(3552)-2 |
JCRB0731
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 12pter>12q24::Xq22>Xqter
| A9(2621)-4 |
JCRB0730
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 16pter>16q24::Xq26>Xqter
| A9(3884)-1 |
JCRB0729
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 17pter>17q11::Xq11>Xqter
| A9(7151)-3 |
JCRB0728
| more |
|
| human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome Xpter>Xq26::3p12>3pter
| A9(0439)-1 |
JCRB0732
| more |
|
|
human chromosome-introduced |
Page Top
| | | | |
| human monochromosomal hybrid panel | |
| |
| |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 1
| A9(Neo1) |
JCRB2201
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 2
| A9(Neo2) |
JCRB2202
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 3
| A9(Neo3) |
JCRB2203
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 4
| A9(Neo4) |
JCRB2204
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 5
| A9(Neo5) |
JCRB2205
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 6
| A9(Neo6) |
JCRB2206
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 7
| A9(Neo7) |
JCRB2207
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 8
| A9(Neo8) |
JCRB2208
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 9
| CHO(His9) |
JCRB2209
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #10
| A9(Bsr10) |
JCRB2210
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #11
| A9(neo11) |
JCRB2211
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #12
| A9(Neo12) |
JCRB2212
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #13
| A9(Hygro13) |
JCRB2213
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #14
| A9(Hygro14) |
JCRB2214
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #15
| A9(Neo15) |
JCRB2215
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #16
| A9(Neo16) |
JCRB2216
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #17
| A9(Neo17) |
JCRB2217
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #18
| A9(Neo18) |
JCRB2218
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #19
| A9(Neo19) |
JCRB2219
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #20
| A9(Neo20) |
JCRB2220
| more |
|
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #21
| A9(Hygro21) |
JCRB2221
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #22
| A9(Hygro22) |
JCRB2222
| more |
*8) |
| human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome X
| A9(BsrX) |
JCRB2223
| more |
|
|
human |
Page Top
| | | | |
| ***** | |
| |
| |
| human |
*****
|
*****
| Pso-1 |
JCRB0641
| more |
*1) |
| human |
*****
|
*****
| Pso-2 |
JCRB0642
| more |
*1) |
| human |
*****
|
*****
| Pso-3 |
JCRB0643
| more |
*1) |
| human |
*****
|
*****
| Pso-4 |
JCRB0644
| more |
*1) |
| human |
*****
|
*****
| Pso-5 |
JCRB0645
| more |
*1) |
| human |
*****
|
*****
| Pso-6 |
JCRB0646
| more |
*1) |
| human |
*****
|
*****
| Pso-7 |
JCRB0647
| more |
*1) |
|
human |
Page Top
| | | | |
| adrenal cortex | |
| |
| |
| human |
adrenal cortex
|
adenocarcinoma
| SW-13 |
JCRB9069
| more |
|
|
human |
Page Top
| | | | |
| bladder | |
| |
| |
| human |
bladder
|
bladder carcinoma, contamination by T24 cells has been suspected
| EJ-1 |
JCRB0710
| more |
|
| human |
bladder
|
urinary bladder carcinoma
| KMBC-2 |
JCRB1148
| more |
|
| human |
bladder
|
urinary bladder carcinoma
| T24 |
JCRB0711
| more |
|
|
human |
Page Top
| | | | |
| bone marrow stroma | |
| |
| |
| human |
bone marrow stroma
|
bone marrow stromal cell from a myelogenous leukemia patient
| FS-1 |
IFO50477
| more |
|
|
human |
Page Top
| | | | |
| colon | |
| |
| |
| human |
colon
|
adenocarcinoma
| CCK-81 |
JCRB0208
| more |
|
| human |
colon
|
adenocarcinoma
| CoCM-1 |
JCRB0257
| more |
|
| human |
colon
|
adenocarcinoma
| COLO201 |
JCRB0226
| more |
|
| human |
colon
|
adenocarcinoma
| COLO320 DM |
JCRB0225
| more |
|
| human |
colon
|
adenocarcinoma
| DLD-1 |
JCRB9094
| more |
|
| human |
colon
|
adenocarcinoma
| WiDr |
JCRB0224
| more |
|
| human |
colon
|
adenocarcinoma
| WiDr |
IFO50043
| more |
|
| human |
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
| LoVo |
IFO50067
| more |
|
| human |
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
| LoVo |
JCRB9083
| more |
|
| human |
colon
|
adenocarcinoma, from familial adenomatous polyposis patient, reduction of APC gene expression
| OUMS-23 |
JCRB1022
| more |
|
| human |
colon
|
adenocarcinoma, moderately differentiated
| HCC-56 |
JCRB1037
| more |
|
| human |
colon
|
colon
| Human Mucosal cells |
JCRB9116
| more |
*1) |
| human |
colon
|
established from normal colon, fibroblast, (the lot in cellbank does not grow)
| CCD-33Co |
IFO50483
| more |
|
| human |
colon
|
established from normal colonic tissue, epithelial-like, (distribution finished)
| CCD 841 CoN |
IFO50482
| more |
*1) |
|
human |
Page Top
| | | | |
| embryo | |
| |
| |
| human |
embryo
|
fibroblast, fetus, half a body
| NTI-5 |
JCRB0222
| more |
|
| human |
embryo
|
fibroblast, fetus, half body, bottom
| NTI-4 |
JCRB0220
| more |
|
| human |
embryo
|
fibroblast, immortalized after extensive passages, derivative of KMS-6
| KMST-6/T |
JCRB0434
| more |
*1) |
| human |
embryo
|
fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
| KMST-6 |
JCRB0433
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-1 |
JCRB1006.1
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-1F |
JCRB1006.1F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-2 |
JCRB1006.2
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-2F |
JCRB1006.2F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-3 |
JCRB1006.3
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-3F |
JCRB1006.3F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-4 |
JCRB1006.4
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-4F |
JCRB1006.4F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-5 |
JCRB1006.5
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-5F |
JCRB1006.5F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-6 |
JCRB1006.6
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-6F |
JCRB1006.6F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-7 |
JCRB1006.7
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-7F |
JCRB1006.7F
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-8 |
JCRB1006.8
| more |
|
| human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
| OUMS-36T-8F |
JCRB1006.8F
| more |
|
| human |
embryo
|
fibroblast, immortalized by mutant p53 and X-ray, derivative of OUMS-24
| OUMS-24/P6X |
JCRB1051
| more |
|
| human |
embryo
|
fibroblast, normal diploid
| KMS-6 |
JCRB0432
| more |
|
| human |
embryo
|
limb interstitial tissue, normal diploid fibroblast
| Miz-1 |
IFO50300
| more |
|
| human |
embryo
|
normal embryonic fibroblast
| OUMS-36 |
JCRB1006.0
| more |
|
| human |
embryo
|
whole fetus, normal diploid fibroblast
| HE-1 |
IFO50297
| more |
|
|
human |
Page Top
| | | | |
| epidermoid carcinoma | |
| |
| |
| human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF receptor
| A-431 |
IFO50411
| more |
|
| human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
| A-431 |
JCRB0004
| more |
|
| human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
| A-431 |
JCRB9009
| more |
|
|
human |
Page Top
| | | | |
| esophagus | |
| |
| |
| human |
esophagus
|
squamous carcinoma
| T.T |
JCRB0262
| more |
|
| human |
esophagus
|
squamous carcinoma, established through nude mice transplant
| T.Tn |
JCRB0261
| more |
|
| human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE140 |
JCRB1063
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE170 |
JCRB1082
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE220 |
JCRB1086
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE110 |
JCRB1064
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE150 |
JCRB1095
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE50 |
JCRB0189
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE70 |
JCRB0190
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE180 |
JCRB1083
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE270 |
JCRB1087
| more |
*6) |
| human |
esophagus
|
squamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
| KYSE30 |
JCRB0188
| more |
*6) |
|
human |
Page Top
| | | | |
| HeLa-contaminant | |
| |
| |
| human |
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
| J-111 |
JCRB0073
| more |
|
| human |
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
| J-111 |
IFO50005
| more |
|
| human |
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
| WISH |
IFO50004
| more |
|
| human |
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
| FL* |
JCRB9016
| more |
*1) |
| human |
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
| Chang Liver |
IFO50016
| more |
|
| human |
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
| Chang Liver |
JCRB9066
| more |
|
| human |
HeLa-contaminant
|
originally established from oral epidermoid carcinoma, HeLa-contaminated
| KB |
JCRB9027
| more |
|
| human |
HeLa-contaminant
|
originally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
| HSGc-C5 |
JCRB1070
| more |
|
|
human |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| human |
hemo-lymphocytic
|
B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant
| WIL2-NS |
JCRB9063
| more |
|
| human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
| BSL2KA |
JCRB1042
| more |
|
| human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
| AT(L)5KY |
JCRB0331
| more |
*2) |
| human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
| AT(L)6KY |
JCRB0332
| more |
*2) |
| human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
| AT(L)7KY |
JCRB0333
| more |
*2) |
| human |
hemo-lymphocytic
|
EBV-infected NK-like cell line, IL-2 dependent
| KAI3 |
IFO50518
| more |
|
| human |
hemo-lymphocytic
|
eliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
| EB-3 |
IFO50028
| more |
*1) |
| human |
hemo-lymphocytic
|
established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
| HS-Sultan |
JCRB9062
| more |
|
| human |
hemo-lymphocytic
|
established from normal blood, IgM secreting
| RPMI 1788 |
IFO50037
| more |
|
| human |
hemo-lymphocytic
|
established from normal blood, IgM secreting
| RPMI 1788 |
JCRB0035
| more |
|
| human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I antigen-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| MT-4 |
JCRB0135
| more |
*2) |
| human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| MT-2 |
JCRB1210
| more |
*2) |
| human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| MT-3 |
JCRB1217
| more |
*2) |
| human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| MT-4 |
JCRB1216
| more |
*2) |
| human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
| CCRF-SB |
JCRB0032
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
| CCRF-SB |
IFO50026
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic, double Philadelphia chromosomes
| TMD5 |
IFO50516
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, bone marrow mononuclear cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL
| MY |
JCRB0158.0
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
| MY-M12 |
JCRB0158.1
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
| MY-M13 |
JCRB0158.2
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic
| MOLT-3 |
JCRB9048
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
| CPT-K5 |
JCRB1067
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic, Ph1 chromosome-positive
| PALL-2 |
JCRB1345
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute lymphoblastoid
| BALL-1 |
JCRB0071
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute lymphocytic
| NALL-1 |
JCRB1332
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
| CMK-11-5 |
IFO50430
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
| CMK-86 |
IFO50428
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
| MKPL-1 |
JCRB1325
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic
| P31/FUJ |
JCRB0091
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic
| THP-1 |
JCRB0112
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic
| THP-1 |
JCRB0112.1
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1
| NOMO-1/ADM |
JCRB1069
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic, NOMO-1-derivative adapted to serum-free medium
| NOMO-1s |
IFO50475
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute monocytic, promonocytic leukemia cells
| NOMO-1 |
IFO50474
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloblastic
| KG-1 |
JCRB0065
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloblastic
| KO52 |
JCRB0123
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination of K562 has been suspected.
| KO51 |
JCRB0122
| more |
*5) |
| human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination with HL60 has been suspected.
| P39/TSU |
JCRB0092
| more |
*5) |
| human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, GM-CSF dependent
| SKNO-1 |
JCRB1170
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myelogenous
| KG-1 |
JCRB9051
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloid
| Kasumi-1 |
JCRB1003
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloid
| Kasumi-6 |
JCRB1024
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloid
| KY821 |
JCRB0105
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth
| NKM-1 |
IFO50476
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloid, subclone of KY821
| KY821A3 |
JCRB0105.1
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute myeloperoxidase-negative
| Kasumi-3 |
JCRB1004
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute non T lymphoblastic
| LC4-1 |
JCRB0114
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute non T non B lymphoblastic
| P30/OHK |
JCRB0094
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute pre B lymphoblastic, B cell line
| NAGL-1 |
IFO50479
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute promyelocytic
| PL-21 |
JCRB1319
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
| HL-60 |
IFO50022
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
| HL60RG |
JCRB0006
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute promyelotic
| HL60(S) |
JCRB0163
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute promyelotic, differentiation-inducible
| HL60 |
JCRB0085
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| CCRF-CEM |
JCRB0033
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| CCRF-CEM |
IFO50412
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| CCRF-CEM |
JCRB9023
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| CCRF-HSB2 |
JCRB0031
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| MOLT-4 |
JCRB9031
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| MOLT-4 |
IFO50362
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| MOLT-4F |
JCRB0021
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
| TALL-1 |
JCRB0086
| more |
|
| human |
hemo-lymphocytic
|
leukemia, acute T lymphocytic
| PEER |
JCRB0830
| more |
|
| human |
hemo-lymphocytic
|
Leukemia, adult T cell, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| MT-1 |
JCRB1209
| more |
*2) |
| human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic
| MEG-01 |
IFO50151
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01-derivative
| MEG-01s |
IFO50473
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium
| MEG-01SSF |
IFO50294
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myelocytic, Ph1-positive
| KCL-22 |
JCRB1317
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, adriamycin resistant derivative of K562
| K562/ADM |
JCRB1002
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, differentiation-inducible
| K562 |
JCRB0019
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, megakaryoblastic cell line
| MEG-A2 |
IFO50478
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, Ph1 chromosome-positive
| NC02 |
IFO50525
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myeloid
| KU812 |
JCRB0104
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myeloid
| KU812 |
IFO50363
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myeloid
| KU812E |
JCRB0104.1
| more |
|
| human |
hemo-lymphocytic
|
leukemia, chronic myeloid
| KU812F |
JCRB0104.2
| more |
|
| human |
hemo-lymphocytic
|
leukemia, erythroid
| HEL |
JCRB0062
| more |
|
| human |
hemo-lymphocytic
|
leukemia, NK cell-like, IL-2 dependent
| KHYG-1 |
JCRB0156
| more |
|
| human |
hemo-lymphocytic
|
leukemia, NK-like T cell line
| MTA |
IFO50513
| more |
|
| human |
hemo-lymphocytic
|
leukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
| JKT-beta-del |
JCRB0147
| more |
|
| human |
hemo-lymphocytic
|
lymphoblast, Contamination of Raji cells has been suspected.
| NC-37 |
IFO50039
| more |
|
| human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
| RBL162T |
JCRB0328
| more |
*2) |
| human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
| RBL182T |
JCRB0330
| more |
*2) |
| human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
| RBL221T |
JCRB0329
| more |
*2) |
| human |
hemo-lymphocytic
|
lymphocyte, peripheral
| HLCL-1 |
JCRB0041
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, anaplastic giant cell, Ki-1(CD30)-positive
| Ki-JK |
JCRB1065
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's
| Daudi |
JCRB9071
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's
| Namalwa |
IFO50040
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's
| P32/ISH |
JCRB0095
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's
| RAJI |
JCRB9012
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's
| Raji |
IFO50046
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's (EBV negative)
| Ramos(RA1) |
JCRB9119
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
| KHM-10B |
JCRB0165
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
| U937 |
JCRB9021
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
| U-937 |
IFO50038
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, from Hodgkin's
| HD-70 |
JCRB1335
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, histiocytic, highly susceptible clone of U937 for HIV
| U937 cl1-14 |
JCRB0116.1
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, histiocytic, low susceptible clone of U937 for HIV
| U937 cl1-22 |
JCRB0116.2
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant
| A3/KAW |
JCRB0101
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant
| RC-K8 |
JCRB1334
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant (arising at brain). This cell line is different from JCRB0157 TK.
| TK |
JCRB1206
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant B lymphoma
| B104 |
JCRB0117
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
| B104-R3 |
JCRB0117.1
| more |
*1) |
| human |
hemo-lymphocytic
|
lymphoma, malignant, B-cell
| TK |
JCRB0157
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
| A4/Fuk |
JCRB0097
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, malignant, hairy B-cell line
| MLMA |
JCRB0146
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, monocytic, non-Hodgkin's
| SCC-3 |
JCRB0115
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, non-Hodgkins
| KML-1 |
JCRB1347
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, non-Hodikin's, Ki-1-positive
| DL-40 |
JCRB1337
| more |
|
| human |
hemo-lymphocytic
|
lymphoma, splenic, B cell line with cytoplasmic villi
| SLVL |
JCRB0159
| more |
|
| human |
hemo-lymphocytic
|
myelo dysplastic syndrome
| SKM-1 |
JCRB0118
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMM-1 |
JCRB1180
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-20 |
JCRB1196
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-21BM |
JCRB1185
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-26 |
JCRB1187
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-27 |
JCRB1188
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-28BM |
JCRB1192
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-28PE |
JCRB1191
| more |
|
| human |
hemo-lymphocytic
|
myeloma
| KMS-34 |
JCRB1195
| more |
|
| human |
hemo-lymphocytic
|
myeloma, IL-6-dependent, growth is very slow
| FLAM-76 |
JCRB1346
| more |
|
| human |
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
| KMS-12-BM |
JCRB0429
| more |
|
| human |
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
| KMS-12-PE |
JCRB0430
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple
| RPMI 8226 |
IFO50013
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple
| RPMI 8226 |
JCRB0034
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
| IM-9 |
JCRB0024
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
| IM-9 |
IFO50025
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple, IgG kappa-secreting, EBNA(-)
| KMS-11 |
JCRB1179
| more |
|
| human |
hemo-lymphocytic
|
myeloma, multiple, with hyperamylasemia.
| KHM-1B |
JCRB0133
| more |
|
| human |
hemo-lymphocytic
|
myeloma, secreting IgD
| delta-47 |
JCRB1344
| more |
|
| human |
hemo-lymphocytic
|
xeroderma pigmentosum (A), lymphoblastoid
| XPL15OS |
JCRB0307
| more |
*2) |
| human |
hemo-lymphocytic
|
xeroderma pigmentosum (C), lymphoblastoid
| XPL3KA |
JCRB0306
| more |
*2) |
|
human |
Page Top
| | | | |
| intestine | |
| |
| |
| human |
intestine
|
fetal small intestine, normal, (not intestinal epithelial cell)
| FHs 74 Int |
JCRB9076
| more |
|
|
human |
Page Top
| | | | |
| kidney | |
| |
| |
| human |
kidney
|
cell line derived from renal pelvis
| KMPC-3 |
JCRB1150
| more |
|
| human |
kidney
|
renal cancer
| KMRC-20 |
JCRB1071
| more |
|
| human |
kidney
|
renal carcinoma
| KMRM-M1 |
JCRB1014
| more |
|
| human |
kidney
|
renal carcinoma
| VMRC-RCZ |
JCRB0827
| more |
|
| human |
kidney
|
renal cell carcinoma
| VMRC-RCW |
JCRB0813
| more |
|
| human |
kidney
|
renal clear cell carcinoma
| Caki-1 |
JCRB0801
| more |
|
| human |
kidney
|
renal clear cell carcinoma
| KMRC-1 |
JCRB1010
| more |
|
| human |
kidney
|
renal clear cell carcinoma
| KMRC-2 |
JCRB1011
| more |
|
| human |
kidney
|
renal clear cell carcinoma
| KMRC-5 |
JCRB1007
| more |
*4) |
| human |
kidney
|
renal clear cell carcinoma (growth is very slow)
| KMRC-3 |
JCRB1012
| more |
|
| human |
kidney
|
renal leiomyoblastoma
| G-402 |
JCRB9070
| more |
|
| human |
kidney
|
transformed embryonal kidney by adenovirus (type5)
| 293 |
JCRB9068
| more |
|
| human |
kidney
|
Wilms' tumor (embryonal carcinosarcoma of kidney)
| G-401 |
JCRB9065
| more |
|
|
human |
Page Top
| | | | |
| liver, gallbladder | |
| |
| |
| human |
liver, gallbladder
|
bile duct carcinoma
| HuCCT1 |
JCRB0425
| more |
|
| human |
liver, gallbladder
|
bile duct carcinoma
| HuH28 |
JCRB0426
| more |
|
| human |
liver, gallbladder
|
bile duct carcinoma
| OZ |
JCRB1032
| more |
*6) |
| human |
liver, gallbladder
|
gallbladder carcinoma, malignant
| OCUG-1 |
JCRB0191
| more |
|
| human |
liver, gallbladder
|
gallbladder carcinoma, tubular adenocarcinoma, moderately differentiated
| NOZ |
JCRB1033
| more |
*6) |
| human |
liver, gallbladder
|
hepatoblastoma, well differentiated
| HUH-6 Clone 5 |
JCRB0401
| more |
|
| human |
liver, gallbladder
|
hepatoma
| Hep G2 |
JCRB1054
| more |
|
| human |
liver, gallbladder
|
hepatoma
| JHH-1 |
JCRB1062
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma
| JHH-2 |
JCRB1028
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma
| JHH-4 |
JCRB0435
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma
| JHH-5 |
JCRB1029
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma
| JHH-6 |
JCRB1030
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma, differentiated
| HuH-7 |
JCRB0403
| more |
|
| human |
liver, gallbladder
|
hepatoma, HBs antigen-positive
| Alexander cells |
IFO50069
| more |
|
| human |
liver, gallbladder
|
hepatoma, HBs antigen-positive
| PLC/PRF/5 |
JCRB0406
| more |
|
| human |
liver, gallbladder
|
hepatoma, HBs antigen-positive, HBc(-), HBe(-).
| huH-1 |
JCRB0199
| more |
*8) |
| human |
liver, gallbladder
|
hepatoma, HBV-integration
| JHH-7 |
JCRB1031
| more |
*6) |
| human |
liver, gallbladder
|
hepatoma, non-differentiated
| HLE |
JCRB0404
| more |
|
| human |
liver, gallbladder
|
hepatoma, non-differentiated
| HLF |
JCRB0405
| more |
|
| human |
liver, gallbladder
|
liver Ito cells (limited life span)
| LI90 |
JCRB0160
| more |
|
|
human |
Page Top
| | | | |
| lung | |
| |
| |
| human |
lung
|
bronchus, diploid
| CCD-14Br |
JCRB9101
| more |
|
| human |
lung
|
fetal lung, immortalized fibroblast transfected with ts SV40 early gene, derivative of TIG-3 cells
| SVts-8 |
JCRB0506.1
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| Flow2000 |
IFO50089
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| HFL1 |
IFO50074
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| IMR-90 |
JCRB0516
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast
| IMR-90 |
JCRB9054
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| MRC-5 |
JCRB9008
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| MRC-5 |
IFO50073
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| MRC-9 |
JCRB9060
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| MRC-9 |
IFO50072
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| WI-38 |
IFO50075
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast
| WI-38 |
JCRB9017
| more |
*1) |
| human |
lung
|
fetal lung, normal diploid fibroblast (not available)
| Flow2000 |
JCRB0067
| more |
*1) |
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30
| MRC-5-30 |
JCRB0521
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available)
| WI-38-30 |
JCRB0517
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available.)
| MRC-9-30 |
JCRB0524
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
| IMR-90-40 |
JCRB0519
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
| MRC-5-40 |
JCRB0522
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
| WI-38-40 |
JCRB0518
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
| IMR-90-50 |
JCRB0520
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
| MRC-5-50 |
JCRB0523
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20
| TIG-1-20 |
JCRB0501
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30
| TIG-1-30 |
JCRB0502
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40
| TIG-1-40 |
JCRB0503
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50
| TIG-1-50 |
JCRB0504
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60
| TIG-1-60 |
JCRB0505
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 20
| TIG-3-20 |
JCRB0506
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 30
| TIG-3-30 |
JCRB0507
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 40
| TIG-3-40 |
JCRB0508
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 50
| TIG-3-50 |
JCRB0509
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 60
| TIG-3-60 |
JCRB0510
| more |
*3) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20
| TIG-7-20 |
JCRB0511
| more |
|
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 30
| TIG-7-30 |
JCRB0512
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 40
| TIG-7-40 |
JCRB0513
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 50
| TIG-7-50 |
JCRB0514
| more |
*4) |
| human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 60
| TIG-7-60 |
JCRB0515
| more |
*4) |
| human |
lung
|
fetal lung, SV40 virus transformed, derivative of WI-26
| WI-26 VA4 |
JCRB9042
| more |
|
| human |
lung
|
fetal lung, SV40 virus transformed, derivative of WI-38
| WI-38 VA13 sub 2 RA |
JCRB9057
| more |
|
| human |
lung
|
normal lung cells, fibroblastic
| OUS-11 |
JCRB1034
| more |
|
|
human |
Page Top
| | | | |
| lung (cancer) | |
| |
| |
| human |
lung (cancer)
|
adenocarcinoma
| A549 |
IFO50153
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| A549 |
JCRB0076
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| ABC-1 |
JCRB0815
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| RERF-LC-Ad1 |
JCRB1020
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| RERF-LC-Ad2 |
JCRB1021
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| RERF-LC-MS |
JCRB0081
| more |
|
| human |
lung (cancer)
|
adenocarcinoma
| VMRC-LCD |
JCRB0814
| more |
|
| human |
lung (cancer)
|
adenocarcinoma, (distribution is suspended)
| RERF-LC-OK |
JCRB0811
| more |
*5) |
| human |
lung (cancer)
|
adenocarcinoma, intermediately differentiated
| PC-3 |
JCRB0077
| more |
|
| human |
lung (cancer)
|
adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes
| RERF-LC-KJ |
JCRB0137
| more |
|
| human |
lung (cancer)
|
bronchial squamous carcinoma, metastasis to brain
| KNS-62 |
IFO50358
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU65 |
JCRB0079
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU65A |
JCRB0054
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU65B |
JCRB0055
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU65C |
JCRB0056
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU99 |
JCRB0080
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU99A |
JCRB0044
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU99B |
JCRB0057
| more |
|
| human |
lung (cancer)
|
giant cell carcinoma
| LU99C |
JCRB0058
| more |
|
| human |
lung (cancer)
|
small cell carcinoma
| Lu-134-B |
JCRB0169
| more |
|
| human |
lung (cancer)
|
small cell carcinoma
| STC 1 |
JCRB1053
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, classic type
| Lu-134-A-H |
JCRB0235
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, exhibits the same DNA profile as lung squamous carcinoma cell line SK-MES-1. (distribution is suspended)
| RERF-LC-MA |
JCRB0812
| more |
*5) |
| human |
lung (cancer)
|
small cell carcinoma, HTLV-1gene integration
| KHM-3S |
JCRB0138
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, intermediate
| RERF-LC-FM |
JCRB0102
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, intermediate
| SBC-5 |
JCRB0819
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
| SBC-1 |
JCRB0816
| more |
*5) |
| human |
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
| SBC-2 |
JCRB0817
| more |
*5) |
| human |
lung (cancer)
|
small cell carcinoma, oat cell type
| SBC-3 |
JCRB0818
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, PTHrP producing
| MS-1-L |
JCRB1081
| more |
|
| human |
lung (cancer)
|
small cell carcinoma, variant type
| Lu-135 |
JCRB0170
| more |
|
| human |
lung (cancer)
|
squamous carcinoma
| RERF-LC-Sq1 |
JCRB1019
| more |
|
| human |
lung (cancer)
|
squamous carcinoma, PTHrP producing
| HARA |
JCRB1080.0
| more |
|
| human |
lung (cancer)
|
squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
| HARA-B |
JCRB1080.1
| more |
|
| human |
lung (cancer)
|
squamous cell carcinoma
| EBC-1 |
JCRB0820
| more |
|
| human |
lung (cancer)
|
squamous cell carcinoma
| LC-1 sq |
JCRB0258
| more |
|
| human |
lung (cancer)
|
squamous cell carcinoma
| LK-2 |
JCRB0829
| more |
|
| human |
lung (cancer)
|
squamous cell carcinoma
| VMRC-LCP |
JCRB0103
| more |
|
| human |
lung (cancer)
|
squamous cell carcinoma, poorly differentiated, G-CSF and PTHrP producing
| OKa-C-1 |
JCRB1343
| more |
|
|
human |
Page Top
| | | | |
| mammary | |
| |
| |
| human |
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
| YMB-1 |
JCRB0823
| more |
|
| human |
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
| YMB-1-E |
JCRB0825
| more |
|
| human |
mammary
|
breast cancer, target cell of the T-cell killer clone T(cHMC-1)
| HMC-1-8 |
JCRB0166
| more |
|
| human |
mammary
|
mammary carcinoma
| MRK-nu-1 |
JCRB0628
| more |
|
| human |
mammary
|
mammary tumor
| MCF-7 |
JCRB0134
| more |
|
|
human |
Page Top
| | | | |
| melanoma | |
| |
| |
| human |
melanoma
|
malignant melanoma
| Mewo |
JCRB0066
| more |
|
| human |
melanoma
|
malignant melanoma (not available)
| SEKI |
JCRB0620
| more |
*4) |
| human |
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
| GAK |
JCRB0180
| more |
|
| human |
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
| GAK |
IFO50321
| more |
|
| human |
melanoma
|
malignant melanoma, colon
| VMRC-MELG |
JCRB0074
| more |
|
| human |
melanoma
|
malignant melanoma, metastasis to lymph node
| A2058 |
IFO50276
| more |
|
| human |
melanoma
|
malignant melanoma, skin
| G-361 |
JCRB9074
| more |
|
| human |
melanoma
|
malignant melanoma, skin
| G-361 |
IFO50009
| more |
|
| human |
melanoma
|
malignant melanoma, sole, melanin production is poor
| HMY-1 |
JCRB1018
| more |
|
| human |
melanoma
|
skin amelanotic melanoma, 6-thioguanine-resistant
| C32TG |
JCRB0227
| more |
|
|
human |
Page Top
| | | | |
| mesenchymal stem cell | |
| |
| |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub 10F |
JCRB1116
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub621b |
JCRB1112
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub622 |
JCRB1114
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub623 |
JCRB1115
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub625 |
JCRB1155
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub631 |
JCRB1156
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub632 |
JCRB1157
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub633 |
JCRB1158
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub634 |
JCRB1161
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub635 |
JCRB1162
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger
| Yub642 |
JCRB1172
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, bone
| Yub637b |
JCRB1163
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, bone
| Yub642b |
JCRB1174
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, bone marrow
| Yub621BMC |
JCRB1113
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, bone marrow
| Yub636 |
JCRB1169
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, cartilage
| Yub621c |
JCRB1111
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, periosteum
| Yub642p |
JCRB1171
| more |
*7) |
| human |
mesenchymal stem cell
|
from polydactylous finger, skin
| Yub637s |
JCRB1173
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, HPV E6, E7-introduced, limited life span
| UE6E7-16 |
JCRB1160
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
| UE6E7T-11 |
JCRB1149
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
| UE6E7T-12 |
JCRB1151
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
| UE6E7T-2 |
JCRB1133
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
| UE6E7T-3 |
JCRB1136
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
| UE7T-13 |
JCRB1154
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
| UE7T-9 |
JCRB1147
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
| UBE6T-15 |
JCRB1159
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
| UBE6T-6 |
JCRB1140
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
| UBE6T-7 |
JCRB1143
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL502 |
JCRB1125
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL505 |
JCRB1128
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL507 |
JCRB1130
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL508 |
JCRB1194
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL512 |
JCRB1229
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL514 |
JCRB1300
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL516 |
JCRB1302
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL518 |
JCRB1307
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
| PL532 |
JCRB1219
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E6, E7-introduced, limited life span
| UCB408E6E7-31 |
JCRB1108
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E7-introduced, limited life span
| UCB408E7-32 |
JCRB1109
| more |
*7) |
| human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT and HPV E6, E7-introduced, immortalized
| UCB408E6E7TERT-33 |
JCRB1110
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT-immortalized
| UCBTERT-21 |
JCRB1107
| more |
|
| human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, limited life span, (growth is very slow.)
| UCB302MSCs |
JCRB1106
| more |
*7) |
|
human |
Page Top
| | | | |
| muscular system | |
| |
| |
| human |
muscular system
|
muscle, normal diploid fibroblast (not myoblast), PDL=about 30
| TIG-2M-30 |
JCRB0525
| more |
|
|
human |
Page Top
| | | | |
| nasal septum | |
| |
| |
| human |
nasal septum
|
quasi-diploid squamous carcinoma
| RPMI 2650 |
JCRB9058
| more |
|
|
human |
Page Top
| | | | |
| neural | |
| |
| |
| human |
neural
|
astrocytoma, adapted to serum-free medium, derived from Marcus cells, (distribution is suspended)
| SK-MG-1 |
IFO50344
| more |
*5) |
| human |
neural
|
astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
| KINGS-1 |
IFO50435
| more |
|
| human |
neural
|
astrocytoma, GFAP-negative
| Becker |
IFO50289
| more |
|
| human |
neural
|
astrocytoma, GFAP-negative, (distribution is suspended)
| Marcus |
IFO50290
| more |
*5) |
| human |
neural
|
astrocytoma, GFAP-positive
| U-251 MG |
IFO50288
| more |
|
| human |
neural
|
astrocytoma, GFAP-positive
| U-251 MG (KO) |
IFO50285
| more |
|
| human |
neural
|
astrocytoma, thymidine kinase-deficient mutant of U251 MG cells
| B2-17 |
IFO50361
| more |
|
| human |
neural
|
glioblastoma
| A-172 |
JCRB0228
| more |
|
| human |
neural
|
glioblastoma
| KS-1 |
IFO50436
| more |
|
| human |
neural
|
glioblastoma
| YKG-1 |
JCRB0746
| more |
|
| human |
neural
|
glioblastoma multiforme, contamination by U-251 MG was suspected
| TK-1 |
JCRB0128
| more |
*5) |
| human |
neural
|
glioblastoma multiforme, GFAP-negative
| SF126 |
IFO50286
| more |
|
| human |
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant
| YH-13 |
IFO50493
| more |
|
| human |
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
| AM-38 |
IFO50492
| more |
|
| human |
neural
|
glioma, anaplastic, GFAP-positive
| no.10 |
IFO50368
| more |
*8) |
| human |
neural
|
glioma, anaplastic, GFAP-positive
| no.11 |
IFO50369
| more |
*8) |
| human |
neural
|
glioma, derivative of KNS-81 adapted to serum-free medium
| KNS-81-FD |
IFO50444
| more |
|
| human |
neural
|
glioma, FGF-9-producing
| NMC-G1 |
IFO50467
| more |
|
| human |
neural
|
glioma, GFAP and S-100-positive, NSE-negative
| KNS-81 |
IFO50359
| more |
|
| human |
neural
|
glioma, GFAP, S-100 and NSE-negative
| KNS-60 |
IFO50357
| more |
|
| human |
neural
|
glioma, GFAP, vimentin and CD13-positive
| KALS-1 |
IFO50434
| more |
|
| human |
neural
|
glioma, GFAP, vimentin and fibronectin-positive
| GB-1 |
IFO50489
| more |
|
| human |
neural
|
glioma, GFAP-positive, S-100 and NSE-negative
| KNS-42 |
IFO50356
| more |
|
| human |
neural
|
gliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
| KNS-89 |
IFO50360
| more |
*1) |
| human |
neural
|
medulloblastoma
| ONS-76 |
IFO50355
| more |
|
| human |
neural
|
mixed glioma, GFAP-negative, S-100-positive
| KG-1-C |
JCRB0236
| more |
|
| human |
neural
|
neuroblastoma
| IMR-32 |
JCRB9050
| more |
|
| human |
neural
|
neuroblastoma
| IMR-32 |
IFO50283
| more |
|
| human |
neural
|
neuroblastoma
| NB-1 |
JCRB0621
| more |
|
| human |
neural
|
neuroblastoma
| NB-1 |
IFO50295
| more |
|
| human |
neural
|
neuroblastoma
| SCCH-26 |
JCRB0106
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland
| GOTO |
JCRB0612
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland
| NH-12 |
JCRB0833
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland
| TGW |
JCRB0618
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia
| NH-6 |
JCRB0832
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland, serum-free
| GOTO.P3 |
JCRB0612.1
| more |
|
| human |
neural
|
neuroblastoma, adrenal gland, serum-free
| TGW.P3 |
JCRB0618.1
| more |
|
| human |
neural
|
neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
| KP-N-RT-BM-1 |
IFO50432
| more |
|
| human |
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
| KP-N-SI9s |
IFO50433
| more |
|
| human |
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
| KP-N-YN |
IFO50431
| more |
|
| human |
neural
|
neuroblastoma, stage III
| NB(TU)1-10 |
JCRB0154
| more |
|
| human |
neural
|
neuroectodermal tumor
| TASK1 |
JCRB0139
| more |
|
| human |
neural
|
normal fibroblast
| Flow3000 |
JCRB0068
| more |
|
| human |
neural
|
retinoblastoma, bilateral
| NCC-RbC-51 |
JCRB1182
| more |
|
| human |
neural
|
retinoblastoma, bilateral
| NCC-RbC-54 |
JCRB1183
| more |
|
| human |
neural
|
retinoblastoma, bilateral
| NCC-RbC-56 |
JCRB1212
| more |
|
| human |
neural
|
retinoblastoma, bilateral (growth is very slow)
| NCC-RbC-T1 |
JCRB1223
| more |
|
| human |
neural
|
retinoblastoma, unilateral
| NCC-RbC-67 |
JCRB1214
| more |
|
| human |
neural
|
retinoblastoma, unilateral (growth is very slow)
| NCC-RbC-39 |
JCRB1305
| more |
|
| human |
neural
|
retinoblastoma, unilateral (growth is very slow)
| NCC-RbC-57 |
JCRB1190
| more |
|
| human |
neural
|
retinoblastoma, unilateral (growth is very slow)
| NCC-RbC-92 |
JCRB1221
| more |
|
|
human |
Page Top
| | | | |
| oral | |
| |
| |
| human |
oral
|
embryonic palatal mesenchyme, limited life span
| HEPM |
JCRB9095
| more |
|
| human |
oral
|
fibroblast, lip
| KD |
JCRB9103
| more |
|
| human |
oral
|
squamous carcinoma, buccal mucosa
| HO-1-N-1 |
JCRB0831
| more |
|
| human |
oral
|
squamous carcinoma, gingiva
| Ca9-22 |
JCRB0625
| more |
|
| human |
oral
|
squamous carcinoma, mouth
| HSC-2 |
JCRB0622
| more |
|
| human |
oral
|
squamous carcinoma, mouth floor
| HO-1-u-1 |
JCRB0828
| more |
|
| human |
oral
|
squamous carcinoma, mouth, ras P21 expression
| KON |
JCRB0194
| more |
|
| human |
oral
|
squamous carcinoma, oral cavity
| SAT |
JCRB1027
| more |
|
| human |
oral
|
squamous carcinoma, oral cavity
| SKN-3 |
JCRB1039
| more |
|
| human |
oral
|
squamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
| KOSC-3 |
JCRB0127
| more |
*5) |
| human |
oral
|
squamous carcinoma, stage III, oral floor
| KOSC-2 cl3-43 |
JCRB0126.1
| more |
|
| human |
oral
|
squamous carcinoma, tongue
| HSC-3 |
JCRB0623
| more |
|
| human |
oral
|
squamous carcinoma, tongue
| HSC-4 |
JCRB0624
| more |
|
| human |
oral
|
squamous carcinoma, tongue
| SAS |
JCRB0260
| more |
|
| human |
oral
|
squamous carcinoma, tongue
| SCC-4 |
JCRB9118
| more |
|
| human |
oral
|
squamous carcinoma, tongue, serum-free culture
| OSC-19 |
JCRB0198
| more |
|
| human |
oral
|
squamous carcinoma, tongue, serum-free culture
| OSC-20 |
JCRB0197
| more |
|
|
human |
Page Top
| | | | |
| ovary | |
| |
| |
| human |
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU (possible misidentification)
| OVMIU-II |
JCRB1050
| more |
|
| human |
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU-II (possible misidentification)
| OVMIU |
JCRB1049
| more |
|
| human |
ovary
|
adenocarcinoma, exhibits the same DNA profile as OVMIU (possible misidentification)
| OVSAYO |
JCRB1047
| more |
|
| human |
ovary
|
adenocarcinoma, poorly differentiated, (distribution is suspended, possiblity for cross-contamination with SNG-II)
| RTSG |
IFO50318
| more |
*5) |
| human |
ovary
|
clear cell adenocarcinoma
| OVISE |
JCRB1043
| more |
|
| human |
ovary
|
clear cell adenocarcinoma
| OVTOKO |
JCRB1048
| more |
|
| human |
ovary
|
clear cell adenocarcinoma, (very labile for freezing, and the viability after thawing is very low)
| OVMANA |
JCRB1045
| more |
|
| human |
ovary
|
clear cell carcinoma
| RMG-I |
IFO50315
| more |
|
| human |
ovary
|
leiomyosarcoma
| RKN |
JCRB0176
| more |
|
| human |
ovary
|
leiomyosarcoma
| RKN |
IFO50317
| more |
|
| human |
ovary
|
mesonephroid adenocarcinoma
| RMG-I |
JCRB0172
| more |
|
| human |
ovary
|
mesonephroid adenocarcinoma
| RMG-II |
JCRB0172.1
| more |
|
| human |
ovary
|
mesonephroid cancer, (excluded from catalogue)
| RMG-II |
IFO50316
| more |
*1) |
| human |
ovary
|
mucinous cystadenocarcinoma
| MCAS |
JCRB0240
| more |
|
| human |
ovary
|
mucinous cystadenocarcinoma
| RMUG-S |
IFO50320
| more |
|
| human |
ovary
|
mucinous cystadenocarcinoma, (distribution is suspended, possibilty for cross-contamination with SNG-II)
| RMUG-L |
IFO50319
| more |
*5) |
| human |
ovary
|
ovarian carcinoma (growth is extremely slow)
| NCC-OvC-K119 |
JCRB1308
| more |
|
| human |
ovary
|
serous papillary adenocarcinoma
| OVSAHO |
JCRB1046
| more |
|
| human |
ovary
|
serous papillary adenocarcinoma (growth is very slow)
| OVKATE |
JCRB1044
| more |
|
| human |
ovary
|
undifferentiated carcinoma
| TYK-nu |
JCRB0234.0
| more |
|
| human |
ovary
|
undifferentiated carcinoma, ascites
| KURAMOCHI |
JCRB0098
| more |
|
| human |
ovary
|
undifferentiated carcinoma, cisplatin-resistant
| TYK-nu.CP-r |
JCRB0234.1
| more |
|
|
human |
Page Top
| | | | |
| pancreas | |
| |
| |
| human |
pancreas
|
pacnreatic ductal cell carcinoma, secreting PTHrP
| KP-4 |
JCRB0182
| more |
|
| human |
pancreas
|
pancreatic cancer
| MIA PaCa-2 |
JCRB0070
| more |
|
| human |
pancreas
|
pancreatic cancer
| TCC-PAN2 |
JCRB1072
| more |
|
| human |
pancreas
|
pancreatic cancer, adenocarcinoma (distribution is suspended)
| KP-1N |
JCRB0177.0
| more |
*5) |
| human |
pancreas
|
pancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
| KP-1NL |
JCRB0177.1
| more |
*5) |
| human |
pancreas
|
pancreatic cancer, adenosquamous carcinoma
| KP-3 |
JCRB0178.0
| more |
|
| human |
pancreas
|
pancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
| KP-3L |
JCRB0178.1
| more |
|
| human |
pancreas
|
pancreatic cancer, moderately differentiated tubular adenocarcinoma
| SUIT-2 |
JCRB1094
| more |
|
| human |
pancreas
|
pancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
| KP-2 |
JCRB0181
| more |
|
| human |
pancreas
|
pancreatic islat cell carcinoma (somatostatinoma)
| QGP-1 |
JCRB0183
| more |
|
|
human |
Page Top
| | | | |
| placenta | |
| |
| |
| human |
placenta
|
chorio carcinoma, trophoblastic cell line
| BeWo |
JCRB9111
| more |
|
|
human |
Page Top
| | | | |
| prostate gland | |
| |
| |
| human |
prostate gland
|
adenocarcinoma
| PC-3 |
JCRB9110
| more |
|
|
human |
Page Top
| | | | |
| rectum | |
| |
| |
| human |
rectum
|
adenocarcinoma
| CaR-1 |
JCRB0207
| more |
|
| human |
rectum
|
adenocarcinoma
| SW837 |
JCRB9115
| more |
|
| human |
rectum
|
adenocarcinoma, well differentiated
| RCM-1 |
JCRB0256
| more |
|
|
human |
Page Top
| | | | |
| sarcoma | |
| |
| |
| human |
sarcoma
|
benign abdominal desmoid tumor
| D422T |
JCRB9112
| more |
*1) |
| human |
sarcoma
|
chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing
| OUMS-27 |
IFO50488
| more |
|
| human |
sarcoma
|
fibrosarcoma, acetabulum
| HT-1080 |
IFO50354
| more |
|
| human |
sarcoma
|
fibrosarcoma, acetabulum
| HT-1080 |
JCRB9113
| more |
|
| human |
sarcoma
|
liposarcoma
| KMLS-1 |
JCRB0200
| more |
|
| human |
sarcoma
|
osteosarcoma
| G-292 clone A141B1 |
IFO50107
| more |
|
| human |
sarcoma
|
osteosarcoma
| HOS |
IFO50106
| more |
|
| human |
sarcoma
|
osteosarcoma
| HuO9 |
JCRB0427
| more |
|
| human |
sarcoma
|
osteosarcoma
| HuO9N2 |
JCRB0428
| more |
|
| human |
sarcoma
|
osteosarcoma
| MG-63 |
IFO50108
| more |
|
| human |
sarcoma
|
osteosarcoma, femur
| NY |
JCRB0614
| more |
|
| human |
sarcoma
|
osteosarcoma, ilium
| HuO-3N1 |
JCRB0413
| more |
|
| human |
sarcoma
|
rhabdomyosarcoma, embryonal
| RD |
JCRB9072
| more |
|
| human |
sarcoma
|
rhabdomyosarcoma, neck
| KYM-1 |
JCRB0627
| more |
|
| human |
sarcoma
|
small round cell sarcoma
| SCCH-196 |
JCRB0108
| more |
|
|
human |
Page Top
| | | | |
| skin | |
| |
| |
| human |
skin
|
ataxia telangiectasia, fibroblast
| AT1OS |
JCRB0308
| more |
*2) |
| human |
skin
|
ataxia telangiectasia, fibroblast
| AT2KY |
JCRB0316
| more |
*2) |
| human |
skin
|
basal cell nevus syndrome, fibroblasts
| BCNS1KO |
JCRB0324
| more |
*2) |
| human |
skin
|
Bloom's syndrome, fibroblast
| BS2CH |
JCRB0317
| more |
*2) |
| human |
skin
|
Bloom's syndrome, fibroblast, immortalized by hTERT
| BS2CHTERT |
JCRB1061
| more |
|
| human |
skin
|
Cockayne's syndrome, fibroblast
| CS2AW |
JCRB0310
| more |
*2) |
| human |
skin
|
Cockayne's syndrome, fibroblast
| CS2OS |
JCRB0309
| more |
*2) |
| human |
skin
|
Cockayne's syndrome, fibroblast, immortalized by hTERT
| CS2AWTERT |
JCRB1059
| more |
|
| human |
skin
|
Cockayne's syndrome, fibroblast, immortalized by SV40 large T
| CS2OS(SVT) |
JCRB1056
| more |
|
| human |
skin
|
Down's syndrome, foreskin
| Detroit 532 |
JCRB9044
| more |
|
| human |
skin
|
Down's syndrome, skin
| Detroit 529 |
JCRB9043
| more |
*1) |
| human |
skin
|
Down's syndrome, skin
| Detroit 539 |
JCRB9045
| more |
|
| human |
skin
|
familial polyposis coli, fibroblasts
| FPC15JTO |
JCRB0319
| more |
*2) |
| human |
skin
|
familial polyposis coli, fibroblasts
| FPC5JTO |
JCRB0318
| more |
*2) |
| human |
skin
|
Fanconi's anemia, fibroblast
| FA18JTO |
JCRB0315
| more |
*2) |
| human |
skin
|
Fanconi's anemia, fibroblast
| FA9JTO |
JCRB0314
| more |
*2) |
| human |
skin
|
Fanconi's anemia, fibroblast, immortalized by hTERT
| FA9JTOTERT |
JCRB1060
| more |
|
| human |
skin
|
fibroblast from retinoblastoma (bilateral) patient
| RB24KY |
JCRB0312
| more |
*2) |
| human |
skin
|
fibroblast from retinoblastoma (unilateral) patient
| RB28KY |
JCRB0313
| more |
*2) |
| human |
skin
|
fibroblast from retinoblastoma(13q-) patient
| RB16KY |
JCRB0311
| more |
*2) |
| human |
skin
|
galactosemia, skin
| Detroit 510 |
JCRB9104
| more |
|
| human |
skin
|
Gardner's syndrome, fibroblasts
| GS7OJTO |
JCRB0323
| more |
*2) |
| human |
skin
|
Gardner's syndrome, fibroblasts, (M)
| GS33JTO |
JCRB0322
| more |
*2) |
| human |
skin
|
giant keratoacanthoma
| HKA-1 |
JCRB1017
| more |
|
| human |
skin
|
Klinefelter's syndrome, skin
| Dempsey |
JCRB9088
| more |
*1) |
| human |
skin
|
Lesh-Nyhan syndrome, skin fibroblast
| MiTen |
JCRB0072
| more |
|
| human |
skin
|
normal fibroblast
| SF-TY |
JCRB0075
| more |
|
| human |
skin
|
normal fibroblast transfected with HPV16
| HFb16d |
JCRB1008
| more |
|
| human |
skin
|
normal keratinocyte immortalized with HPV16.
| PHK16-0b |
JCRB0141
| more |
|
| human |
skin
|
osteoporosis, skin
| De Gin |
JCRB9078
| more |
|
| human |
skin
|
osteoporosis, skin
| Ran Nor |
JCRB9079
| more |
|
| human |
skin
|
Peutz-Jeghers' syndrome, fibroblasts
| PJS1JTO |
JCRB0320
| more |
*2) |
| human |
skin
|
Peutz-Jeghers' syndrome, fibroblasts
| PJS5JTO |
JCRB0321
| more |
*2) |
| human |
skin
|
skin, normal diploid fibroblast
| ASF-4-1 |
IFO50418
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| ASF-4-2 |
IFO50419
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| Flow7000 |
IFO50079
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| Hs68 |
IFO50350
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-102 |
JCRB0527
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-103 |
JCRB0528
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-104 |
JCRB0529
| more |
*3) |
| human |
skin
|
skin, normal diploid fibroblast
| TIG-105 |
JCRB0530
| more |
*3) |
| human |
skin
|
skin, normal diploid fibroblast
| TIG-106 |
JCRB0531
| more |
*3) |
| human |
skin
|
skin, normal diploid fibroblast
| TIG-107 |
JCRB0532
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-108 |
JCRB0537
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-109 |
JCRB0538
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-110 |
JCRB0543
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-111 |
JCRB0541
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-112 |
JCRB0533
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-113 |
JCRB0539
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-114 |
JCRB0534
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-118 |
JCRB0535
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-119 |
JCRB0540
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-120 |
JCRB0542
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-121 |
JCRB0536
| more |
|
| human |
skin
|
skin, normal diploid fibroblast
| TIG-3S |
JCRB0544
| more |
|
| human |
skin
|
skin, normal diploid fibroblast (growth is slow)
| TIG-101 |
JCRB0526
| more |
|
| human |
skin
|
squamous carcinoma
| HSC-1 |
JCRB1015
| more |
|
| human |
skin
|
squamous carcinoma
| HSC-5 |
JCRB1016
| more |
|
| human |
skin
|
Turner's syndrome, skin
| Detroit 525 |
JCRB9102
| more |
|
| human |
skin
|
Werner's syndrome fibroblast, SV40-infected, contamination by WI-38 was suspected.
| PSV811 |
JCRB0604
| more |
*5) |
| human |
skin
|
xeroderma pigmentosum (A), embryo fibroblast
| XPEMB-1 |
JCRB0325
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (A), fibroblast
| XP35OS |
JCRB0304
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (A), fibroblast
| XP39OS |
JCRB0326
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (A), fibroblast
| XP3OS |
JCRB0303
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by hTERT
| XP39OSTERT |
JCRB1057
| more |
|
| human |
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by SV40 large T
| XP3OS(SVT) |
JCRB1055
| more |
|
| human |
skin
|
xeroderma pigmentosum (A), SV40 transformed
| XP2OS(SV) |
JCRB0301
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (C), fibroblast
| XP40OS |
JCRB0327
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (C), fibroblast, immortalized by hTERT
| XP40OSTERT |
JCRB1058
| more |
|
| human |
skin
|
xeroderma pigmentosum (F), SV40 transformed
| XP2YO(SV) |
JCRB0302
| more |
*2) |
| human |
skin
|
xeroderma pigmentosum (variant type), fibroblast
| XP2SA |
JCRB0305
| more |
*2) |
|
human |
Page Top
| | | | |
| stomach | |
| |
| |
| human |
stomach
|
adenocarcinoma
| NCC-StC-K140 |
JCRB1228
| more |
|
| human |
stomach
|
adenocarcinoma
| RERF-GC-1B |
JCRB1009
| more |
|
| human |
stomach
|
adenocarcinoma, moderately differentiated
| IM95 |
JCRB1075.0
| more |
|
| human |
stomach
|
adenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
| IM95m |
JCRB1075.1
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated
| MKN45 |
JCRB0254
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated
| NUGC-2 |
JCRB0821
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated
| NUGC-3 |
JCRB0822
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated, AFP producing
| FU97 |
JCRB1074
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated, containing signet ring cells
| OCUM-1 |
JCRB0192
| more |
|
| human |
stomach
|
adenocarcinoma, poorly differentiated, signet ring cell carcinoma
| NUGC-4 |
JCRB0834
| more |
|
| human |
stomach
|
adenosquamous carcinoma
| MKN1 |
JCRB0252
| more |
|
| human |
stomach
|
choriocarcinoma arising at stomach from male patient
| SCH |
JCRB0251
| more |
|
| human |
stomach
|
gastric carcinoma, proliferates very slowly (D.T.=2 weeks).
| Takigawa |
JCRB0124
| more |
|
| human |
stomach
|
originally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
| AZ-521 |
JCRB0061
| more |
|
| human |
stomach
|
signet ring cell carcinoma
| KATOIII |
JCRB0611
| more |
|
| human |
stomach
|
tubular adenocarcinoma, moderately differentiated
| MKN74 |
JCRB0255
| more |
|
| human |
stomach
|
tubular adenocarcinoma, moderately differentiated, contamination with MKN74 has been suspected
| MKN28 |
JCRB0253
| more |
|
| human |
stomach
|
tubular adenocarcinoma, well differentiated
| MKN7 |
JCRB1025
| more |
|
|
human |
Page Top
| | | | |
| teratocarcinoma | |
| |
| |
| human |
teratocarcinoma
|
ovarian teratocarcinoma, from ascitic fluid
| PA-1 |
JCRB9061
| more |
|
| human |
teratocarcinoma
|
ovarian teratocarcinoma, HPRT(-) subline of PA-1
| PA-1/6TG-r |
JCRB1052
| more |
|
| human |
teratocarcinoma
|
teratocarcinoma from anterior mediastinum, HST-1 oncogene-expressing
| NCC-IT-A3 |
JCRB1005
| more |
|
|
human |
Page Top
| | | | |
| testis | |
| |
| |
| human |
testis
|
testicular germ cell tumor
| NEC14 |
JCRB0162
| more |
|
| human |
testis
|
testicular germ cell tumor
| NEC8 |
JCRB0250
| more |
|
| human |
testis
|
testicular germ cell tumor, embrional carcinoma
| NCR-G2 |
JCRB1167
| more |
|
| human |
testis
|
testicular germ cell tumor, embrional carcinoma
| NCR-G4 |
JCRB1175
| more |
|
| human |
testis
|
testicular germ cell tumor, embryonal carcinoma
| NCR-G3 |
JCRB1168
| more |
|
| human |
testis
|
testicular germ cell tumor, yolk sac tumor-like characteristics
| NCR-G1 |
JCRB1166
| more |
|
| human |
testis
|
testicular tumor, (embryonal tumor)
| ITO-II |
JCRB0613
| more |
|
|
human |
Page Top
| | | | |
| thymus | |
| |
| |
| human |
thymus
|
undifferentiated thymic carcinoma
| Ty-82 |
JCRB1330
| more |
|
|
human |
Page Top
| | | | |
| thyroid | |
| |
| |
| human |
thyroid
|
non differentiated cancer
| TCO-1 |
JCRB0239
| more |
|
| human |
thyroid
|
thyroid anaplastic carcinoma
| ASH-3 |
JCRB1073
| more |
|
| human |
thyroid
|
thyroid anaplastic carcinoma
| KMH-2 |
JCRB1066
| more |
|
| human |
thyroid
|
thyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
| IHH-4 |
JCRB1079
| more |
|
| human |
thyroid
|
thyroid anaplastic carcinoma, undifferentiated
| 8305C |
JCRB0824
| more |
|
| human |
thyroid
|
thyroid anaplastic carcinoma,(contamination by IHH-4 is suspected.)
| TMH-1 |
JCRB1078
| more |
|
| human |
thyroid
|
thyroid carcinoma
| HTC/C3 |
JCRB0164
| more |
|
| human |
thyroid
|
thyroid carcinoma, undifferentiated
| 8505C |
JCRB0826
| more |
|
| human |
thyroid
|
thyroid carcinoma, undifferentiated, IL-8 producing
| KHM-5M |
JCRB0148
| more |
|
|
human |
Page Top
| | | | |
| umbilical cord | |
| |
| |
| human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
| UC701 |
JCRB1218
| more |
*7) |
| human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
| UC702 |
JCRB1220
| more |
*7) |
| human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
| UC704 |
JCRB1224
| more |
*7) |
|
human |
Page Top
| | | | |
| uterine cervix | |
| |
| |
| human |
uterine cervix
|
cervical carcinoama
| ME-180 |
JCRB0810
| more |
|
| human |
uterine cervix
|
cervical epidermoid cancer
| Ca Ski |
IFO50007
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma
| SKG-I |
IFO50308
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
| SKG-IIIa |
JCRB0232
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
| SKG-IIIa |
IFO50310
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
| SKG-II |
IFO50309
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
| SKG-IIIb |
JCRB0232.1
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
| SKG-IIIb |
IFO50311
| more |
|
| human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type (excluded from catalogue)
| SKG-II |
JCRB0171
| more |
*1) |
| human |
uterine cervix
|
cervical epithelioid carcinoma
| HeLa S3 |
IFO50011
| more |
|
| human |
uterine cervix
|
cervical epitheloid carcinoma, adaptable to a suspension culture
| HeLa S3 |
JCRB9010
| more |
|
| human |
uterine cervix
|
cervical squamous cell carcinoma
| BOKU |
IFO50323
| more |
|
| human |
uterine cervix
|
cervical squamous cell carcinoma
| HCS-2 |
JCRB1203
| more |
|
| human |
uterine cervix
|
endocervical adenocarcinoma
endocervical adenocarcinoma cell line.
| HCA-1 |
JCRB1153
| more |
|
| human |
uterine cervix
|
endocervical small cell carcinoma
| HCSC-1 |
JCRB1205
| more |
|
| human |
uterine cervix
|
epitheloid carcinoma
| HeLa |
JCRB9004
| more |
|
| human |
uterine cervix
|
epitheloid carcinoma
| HeLa 229 |
JCRB9086
| more |
|
| human |
uterine cervix
|
epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
| HeLa TG Cap |
JCRB0215
| more |
|
| human |
uterine cervix
|
epitheloid carcinoma, 6-thioguanine-resistant
| HeLa TG |
JCRB0214
| more |
|
| human |
uterine cervix
|
epitheloid carcinoma, 8-azaguanine-resistant
| HeLa AG |
JCRB0213
| more |
|
| human |
uterine cervix
|
HeLa cell derived, can grow in a serum-free medium
| HeLa.P3(S) |
JCRB0606
| more |
|
| human |
uterine cervix
|
HeLa derivative, can grow in suspension culture
| HeLa S3 (sc) |
JCRB0713
| more |
|
| human |
uterine cervix
|
hERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
| HeLa9903 |
JCRB1318
| more |
|
| human |
uterine cervix
|
normal epithelial cells immortalized with HPV16, EGF-independent
| NCC16-P11 |
JCRB0174.0
| more |
|
| human |
uterine cervix
|
normal keratinocyte immortalized with HPV16
| NCE 16IIA |
JCRB1090
| more |
|
| human |
uterine cervix
|
normal keratinocyte immortalized with HPV16
| NCE16 |
JCRB0140
| more |
|
| human |
uterine cervix
|
serum free adapted HeLa cell line
| HeLa.P3 |
JCRB0649
| more |
|
| human |
uterine cervix
|
serum free adapted HeLa cell line, deposited by original developer
| HeLa.P3 |
JCRB0649.1
| more |
|
|
human |
Page Top
| | | | |
| uterus | |
| |
| |
| human |
uterus
|
endometrial adenocarcinoma
| HEC-1 |
JCRB0042
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-108 |
JCRB1123
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-116 |
JCRB1124
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-151 |
JCRB1122
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-1-A |
JCRB1117
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-1-B |
JCRB1193
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-251 |
JCRB1141
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-265 |
JCRB1142
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-50B |
JCRB1145
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-59 |
JCRB1120
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-6 |
JCRB1118
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| HEC-88nu |
JCRB1121
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| SNG-II |
IFO50312
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| SNG-M |
JCRB0179
| more |
|
| human |
uterus
|
endometrial adenocarcinoma
| SNG-M |
IFO50313
| more |
|
| human |
uterus
|
endometrial adenocarcinoma, (distribution was suspended)
| HEC-155 |
JCRB1127
| more |
*5) |
| human |
uterus
|
endometrial adenocarcinoma, (excluded from catalogue)
| SNG-II |
JCRB0175
| more |
*1) |
| human |
uterus
|
gestational uterine choriocarcinoma
| GCH-nu-YS |
JCRB1201
| more |
|
| human |
uterus
|
gestational uterine choriocarcinoma
| NJG |
IFO50322
| more |
|
| human |
uterus
|
leiomyosarcoma
| SKN |
IFO50314
| more |
|
| human |
uterus
|
leiomyosarcoma
| SKN |
JCRB0173
| more |
|
|
human |
Page Top
| | | | |
| vascular system | |
| |
| |
| human |
vascular system
|
immortalized normal endothelium, contamination by T-24/EJ1 was suspected.
| ECV304 |
JCRB0744
| more |
*5) |
| human |
vascular system
|
normal endothelial cell, umbilical cord
| HUV-EC-C |
IFO50271
| more |
|
|
Indian Muntjak |
Page Top
| | | | |
| skin | |
| |
| |
| Indian Muntjak |
skin
|
used for chromosomal study
| Indian Muntjac |
JCRB9100
| more |
|
|
Indian Muntjak |
Page Top
| | | | |
| thymus | |
| |
| |
| Indian Muntjak |
thymus
|
subline of Mm2T, serum-free
| Mm2T12.P3 |
JCRB0650.1
| more |
|
| Indian Muntjak |
thymus
|
thymus
| Mm2T |
JCRB0609
| more |
*1) |
| Indian Muntjak |
thymus
|
thymus, serum-free adapted Mm2T
| Mm2T.P3 |
JCRB0609.1
| more |
|
|
marsupial (potoroo, rat kangaroo) |
Page Top
| | | | |
| kidney | |
| |
| |
| marsupial (potoroo, rat kangaroo) |
kidney
|
DNA replication study
| Pt K2 |
JCRB0007
| more |
|
| marsupial (potoroo, rat kangaroo) |
kidney
|
kidney
| Pt K1 |
JCRB9039
| more |
|
| marsupial (potoroo, rat kangaroo) |
kidney
|
kidney
| Pt K2 (NBL-5) |
JCRB9052
| more |
|
| marsupial (potoroo, rat kangaroo) |
kidney
|
kidney, epithelial-like
| Pt K2 |
IFO50012
| more |
|
|
mink |
Page Top
| | | | |
| lung | |
| |
| |
| mink |
lung
|
useful for focus forming assays of murine and feline sarcoma virus
| Mv 1 Lu |
JCRB9128
| more |
|
|
monkey, African green |
Page Top
| | | | |
| kidney | |
| |
| |
| monkey, African green |
kidney
|
kidney
| BS-C-1 |
JCRB9011
| more |
*1) |
| monkey, African green |
kidney
|
kidney, highly susceptible to SV40 infection
| CV-1 |
JCRB9049
| more |
|
| monkey, African green |
kidney
|
normal, contact inhibited
| VERO |
JCRB0111
| more |
|
| monkey, African green |
kidney
|
normal, contact inhibited
| VERO |
JCRB9013
| more |
|
| monkey, African green |
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
| VERO 76 |
IFO50410
| more |
|
| monkey, African green |
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
| VERO 76 |
JCRB9007
| more |
|
| monkey, African green |
kidney
|
suitable host for transfection experiments of SV40 vectors
| BS-C-1 |
IFO50413
| more |
|
| monkey, African green |
kidney
|
suitable host for transfection experiments of SV40 vectors
| BS-C-1 |
JCRB9126
| more |
|
| monkey, African green |
kidney
|
SV40 transformed African green monkey kidney
| COS-1 |
JCRB9082
| more |
|
| monkey, African green |
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
| COS-7 |
JCRB9127
| more |
|
| monkey, African green |
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
| COS-7 |
IFO50068
| more |
|
| monkey, African green |
kidney
|
useful to assay mycoplasmas
| Vero |
IFO50471
| more |
|
|
monkey, Cynomolgus |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| monkey, Cynomolgus |
hemo-lymphocytic
|
HSV-immortalized T-cell line, susceptible to SIV
| HSC-F |
JCRB1164
| more |
|
|
monkey, Cynomolgus |
Page Top
| | | | |
| kidney | |
| |
| |
| monkey, Cynomolgus |
kidney
|
MK (JTC-12) cells adapted to serum-free medium
| MK.P3 |
JCRB0607.1
| more |
|
| monkey, Cynomolgus |
kidney
|
other name is JTC-12.P3(F)
| MK.P3(F) |
JCRB0607
| more |
|
|
monkey, Japanese macaque |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| monkey, Japanese macaque |
hemo-lymphocytic
|
Japanese monkey lymphocyte line transformed with HTLV-I. (This cell line is supplied from National Institute of Biomedical Innovation.)
| Si-1 |
JCRB1369
| more |
*2) |
| monkey, Japanese macaque |
hemo-lymphocytic
|
STLV-I carrying Japanese monkey lymphoid cell line. (This cell line is supplied from National Institute of Biomedical Innovation.)
| Si-2 |
JCRB1321
| more |
*2) |
|
monkey, rhesus |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| monkey, rhesus |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
| HSR-5 |
JCRB1211
| more |
|
|
mosquito |
Page Top
| | | | |
| hatched larvae | |
| |
| |
| mosquito |
hatched larvae
|
useful for replication of flavivirus
| C6/36 |
IFO50010
| more |
|
|
mouse x human |
Page Top
| | | | |
| antibody-producing hybridoma | |
| |
| |
| mouse x human |
antibody-producing hybridoma
|
4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
| 4G12 hybridoma |
IFO50090
| more |
|
|
mouse x rat |
Page Top
| | | | |
| antibody-producing hybridoma | |
| |
| |
| mouse x rat |
antibody-producing hybridoma
|
anti-murine IL-2 receptors (rat antibody)
| 7D4 |
JCRB9092
| more |
|
|
mouse x rat |
Page Top
| | | | |
| cybrid | |
| |
| |
| mouse x rat |
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
| PCC4 Type I |
JCRB0204
| more |
*1) |
| mouse x rat |
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
| PCC4 TypeIII |
JCRB0203
| more |
|
|
mouse x rat |
Page Top
| | | | |
| neural | |
| |
| |
| mouse x rat |
neural
|
N18TG2 x Fischer rat embryonic neural retina
| N18-RE-105 |
IFO50221
| more |
|
|
mouse |
Page Top
| | | | |
| adrenal cortex | |
| |
| |
| mouse |
adrenal cortex
|
adrenocortical tumor, steroid-secreting, (LAF1 mouse)
| Y-1 |
JCRB9056
| more |
|
|
mouse |
Page Top
| | | | |
| antibody-producing hybridoma | |
| |
| |
| mouse |
antibody-producing hybridoma
|
A2B5 antibody, recognizing a glycolipid expressed in neural tissue
| A2B5 clone 105 |
IFO50284
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-11-deoxycortisol, IgG
| S.CET.M8.1.1 |
JCRB0011
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
| OHP101.B11.1 |
JCRB1316.2
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
| OHP138.H8.1 |
JCRB1316.3
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
| OHP1E9.3.1 |
JCRB1316.4
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
| OHP57.G6.1 |
JCRB1316.1
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
| OHP7D7.2.3 |
JCRB1316.6
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
| F56 |
JCRB1189
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
| F25 |
JCRB1323
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
| F119 |
JCRB1324
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG1(k)
| DIG104.10H.1 |
JCRB1213.3
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG2b(k)
| DIG222.4D.5 |
JCRB1213.2
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
| 4-8H |
JCRB0083
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
| SJK-237-71 |
JCRB9032
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
| STK1 |
JCRB9033
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
| 16-8 |
JCRB0013
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
| 19-7 |
JCRB0014
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.1.3 |
JCRB1222.01
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.15.3 |
JCRB1222.09
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.17.2 |
JCRB1222.03
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.31.3 |
JCRB1222.12
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.6.5 |
JCRB1222.02
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH1.9.3 |
JCRB1222.06
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH2.4.2 |
JCRB1222.15
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
| HGH2.6.1 |
JCRB1222.05
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(lambda)
| HGH2.15.4 |
JCRB1222.16
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2a(k)
| HGH1.35.2 |
JCRB1222.04
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
| HGH1.11.1 |
JCRB1222.08
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
| HGH1.32.4 |
JCRB1222.13
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
| HGH1.41.1 |
JCRB1222.10
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
| HGH1.46.1 |
JCRB1222.11
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
| HGH1.8.1 |
JCRB1222.07
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-human growth hormone receptor antibody-producing, subclass IgG1(k)
| GHBP116 |
JCRB1226
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse)
| MB86 |
JCRB0090
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-metallothionein antibody-producing, IgG1(k)
| MT-45-5-3 |
JCRB1304
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
| MOR35.4.12 |
JCRB1342.02
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
| MOR8.2.1 |
JCRB1342.01
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
| MOR83.3.10 |
JCRB1342.05
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-primase complexed with DNA polymerase alpha
| 4-2D |
JCRB0084
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-rat neutrophil, IgG1
| RP-1 |
JCRB0195
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-rat neutrophil, IgM
| RP-3 |
JCRB0196
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-scopolamine antibody-producing. IgG1(k)
| SC78.H81.C81.A9 |
JCRB1301
| more |
|
| mouse |
antibody-producing hybridoma
|
anti-zearalenone, IgG1(lambda)
| ZEN |
JCRB1311
| more |
|
| mouse |
antibody-producing hybridoma
|
HPSV178 antibody, against GPI-anchorless splice variant of prion protein
| HPSV178-4-3 |
JCRB1314
| more |
|
| mouse |
antibody-producing hybridoma
|
MSW113 antibody, recognizing a cancer-associated olygosaccharide
| NKY113 |
IFO50279
| more |
|
| mouse |
antibody-producing hybridoma
|
RC1 antibody, recognizing undifferentiated neural cell-specific antigen
| RC1 |
IFO50466
| more |
|
|
mouse |
Page Top
| | | | |
| ascites | |
| |
| |
| mouse |
ascites
|
Ehrlich ascites
| JTC-11 |
JCRB0424
| more |
|
| mouse |
ascites
|
Ehrlich-Lettre ascites carcinoma
| Ehrlich ascites |
JCRB9090
| more |
|
|
mouse |
Page Top
| | | | |
| bladder | |
| |
| |
| mouse |
bladder
|
bladder carcinoma
| MBT2 |
IFO50041
| more |
|
|
mouse |
Page Top
| | | | |
| bone marrow | |
| |
| |
| mouse |
bone marrow
|
mesenchymal cell line
| 9-15c |
JCRB1181
| more |
|
| mouse |
bone marrow
|
mesenchymal stem cell line
| HS-22 |
JCRB1215
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM10 |
JCRB1176
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM3 |
JCRB1134
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM4 |
JCRB1135
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM5 |
JCRB1178
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM6 |
JCRB1202
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM7 |
JCRB1204
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUM9 |
JCRB1139
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUSA-A1 |
JCRB1119
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUSA-H1 |
JCRB1129
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| KUSA-O |
JCRB1132
| more |
|
| mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
| NRG |
JCRB1138
| more |
|
|
mouse |
Page Top
| | | | |
| embryo | |
| |
| |
| mouse |
embryo
|
3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
| C3H/MCA clone 15 |
IFO50042
| more |
|
| mouse |
embryo
|
C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse)
| MCA-TCL16 |
JCRB0712
| more |
|
| mouse |
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
| 3T3 L1 |
JCRB9014
| more |
|
| mouse |
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
| 3T3-L1 |
IFO50416
| more |
|
| mouse |
embryo
|
fibroblast, collagen-secreting, (Swiss albino mouse)
| 3T6-Swiss albino |
JCRB9059
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
| BALB/3T3 A31-1-1 |
JCRB0601
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
| BALB/3T3 clone A31 |
JCRB9005
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
| C3H/10T1/2 clone 8 |
JCRB9080
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
| C3H/10T1/2-clone 8 |
JCRB0003
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
| C3H/10T1/2-clone8 |
IFO50415
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
| C3H/10T1/2 clone 8 |
JCRB0602
| more |
*1) |
| mouse |
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
| NIH 3T3 p-7 cl-3 |
IFO50019
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
| NIH/3T3 clone 5611 |
JCRB0615
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
| 3T3-Swiss albino |
JCRB9019
| more |
|
| mouse |
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
| 3T3-Swiss albino |
IFO50417
| more |
|
| mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
| A31-714 C4 |
IFO50021
| more |
|
| mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
| Balb/c 3T3 A31-1-13 |
IFO50299
| more |
|
| mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
| Balb/c 3T3 A31-I-1 |
IFO50298
| more |
|
| mouse |
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
| A31-1-1 |
JCRB1356
| more |
|
| mouse |
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
| Balb/3T3-A31-1-1 |
IFO50070
| more |
|
| mouse |
embryo
|
H-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
| Bhas 42 |
JCRB0149
| more |
|
| mouse |
embryo
|
SV40 virus-transformed BALB/3T3, (BALB/c mouse)
| SV-T2 |
JCRB9099
| more |
|
|
mouse |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| mouse |
hemo-lymphocytic
|
erythroleukemia
| B8/3 |
JCRB0238
| more |
|
| mouse |
hemo-lymphocytic
|
L5178Y derivative, abnormal cell division at non-permissive temperature
| L5178Y ts2 |
JCRB0723
| more |
|
| mouse |
hemo-lymphocytic
|
L5178Y derivative, micronucleation at non-permissive temperature
| L5178Y ts39 |
JCRB0724
| more |
|
| mouse |
hemo-lymphocytic
|
L5178Y derivative, thymidine kinase +/- heterozygotic line
| L5178Y TK+/-3.7.2c |
JCRB0709.1
| more |
|
| mouse |
hemo-lymphocytic
|
leukemia, B cell, (BALB/c mouse)
| BCL1 Clone CW13.20 |
JCRB9117
| more |
|
| mouse |
hemo-lymphocytic
|
leukemia, lymphocytic, (DBA/2 mouse)
| L1210 |
JCRB9026
| more |
|
| mouse |
hemo-lymphocytic
|
leukemia, myelomonocytic, macrophage-like, (BALB/c mouse)
| WEHI-3 |
JCRB9093
| more |
|
| mouse |
hemo-lymphocytic
|
leukemia, spontaneous myeloblastic, differentiation-inducible, (SL mouse)
| M1-T22 |
JCRB0110
| more |
|
| mouse |
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
| P388D1 |
IFO50036
| more |
|
| mouse |
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
| P388-D1 |
JCRB0016
| more |
|
| mouse |
hemo-lymphocytic
|
lymphoid neoplasm, methylcholanthrene-induced, (DBA/2 mouse)
| P388 |
JCRB0017
| more |
|
| mouse |
hemo-lymphocytic
|
lymphoma, methylcholanthrene induced, (DBA/2 mouse)
| L5178Y |
JCRB0709
| more |
|
| mouse |
hemo-lymphocytic
|
lymphoma, T cell lymphoma, (AKR/J mouse)
| BW5147.G.1.4.OUA-R.1 |
JCRB9002
| more |
|
| mouse |
hemo-lymphocytic
|
mast cell line
| PB-3c |
IFO50267
| more |
|
| mouse |
hemo-lymphocytic
|
mastocytoma, (DBA/2 mouse)
| P-815 |
JCRB0078
| more |
|
| mouse |
hemo-lymphocytic
|
monocyte-macrophage, (BALB/c mouse)
| J774A.1 |
JCRB9108
| more |
|
| mouse |
hemo-lymphocytic
|
monocyte-macrophage, IL-1-producing, (BALB/c mouse)
| J774.1 |
JCRB0018
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma
| P3U1 |
JCRB0708
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, (BALB/c mouse)
| PAI |
JCRB0113
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, 8-azaguanine-resistant, (BALB/c mouse)
| P3/NS1/1-Ag4-1 |
JCRB0009
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, IgG1 secreting, (BALB/c mouse)
| P3.6.2.8.1 |
JCRB9109
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant
| Sp2/O-Ag14 |
JCRB9084
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse)
| P3X63-Ag8.653 |
JCRB9030
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, ourbain resistant
| MPC 11 OUAr |
JCRB9106
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse)
| P3X63Ag8U.1 |
JCRB9085
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse)
| P3X63Ag8 |
JCRB9105
| more |
|
| mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant
| P3/NS1/1-Ag4-1(NS-1) |
JCRB9107
| more |
|
| mouse |
hemo-lymphocytic
|
myelomonocyte, (BALB/c mouse)
| WEHI-3b |
IFO50296
| more |
|
| mouse |
hemo-lymphocytic
|
spontaneous myeloid leukemia, differentiation into macrophage/granulocyte, (SL mouse)
| M1 |
IFO50006
| more |
|
| mouse |
hemo-lymphocytic
|
spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse)
| Mm1 |
IFO50008
| more |
|
| mouse |
hemo-lymphocytic
|
thymic leukemia, (GR/A mouse)
| GRSL |
IFO50111
| more |
|
|
mouse |
Page Top
| | | | |
| kidney | |
| |
| |
| mouse |
kidney
|
tubule cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
| TKC2 |
IFO50373
| more |
|
|
mouse |
Page Top
| | | | |
| liver | |
| |
| |
| mouse |
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
| TLR2 |
IFO50379
| more |
|
| mouse |
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
| TLR3 |
IFO50380
| more |
|
| mouse |
liver
|
liver stromal cell line
| FLS3 |
IFO50377
| more |
|
| mouse |
liver
|
liver stromal cell line
| FLS5 |
IFO50378
| more |
|
| mouse |
liver
|
normal liver-derived, (C3H/An mouse)
| NCTC Clone 1469 |
JCRB9075
| more |
|
| mouse |
liver
|
normal liver-derived, (C3H/An mouse)
| NCTC clone 1469 |
IFO50080
| more |
|
|
mouse |
Page Top
| | | | |
| lung | |
| |
| |
| mouse |
lung
|
Lewis lung cancer-derived cell line, (C57BL mouse)
| 3LL |
JCRB1348
| more |
|
| mouse |
lung
|
Lewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
| Ex-3LL |
JCRB1349
| more |
|
|
mouse |
Page Top
| | | | |
| mammary | |
| |
| |
| mouse |
mammary
|
FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse)
| tsFT101 |
JCRB0706
| more |
|
| mouse |
mammary
|
FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse)
| ts85 |
JCRB0705
| more |
|
| mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
| BALB-MC |
JCRB0233.0
| more |
|
| mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
| BALB-MC.D3 |
JCRB0233.1
| more |
|
| mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
| BALB-MC.E12 |
JCRB0233.2
| more |
|
| mouse |
mammary
|
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
| FM3A APRT~ |
JCRB0703
| more |
|
| mouse |
mammary
|
mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
| FM3A HPRT~ |
JCRB0702
| more |
|
| mouse |
mammary
|
mammary carcinoma, spontaneously obtained, (C3H/He mouse)
| FM3A |
JCRB0701
| more |
|
| mouse |
mammary
|
mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
| FM3A TK~ |
JCRB0704
| more |
|
| mouse |
mammary
|
mammary tumor, producing MuMTV, (DD/Tbr mouse)
| DD-762 |
JCRB1077
| more |
|
| mouse |
mammary
|
spontaneous mammary tumor
| MMT 060562 |
JCRB9077
| more |
|
|
mouse |
Page Top
| | | | |
| melanoma | |
| |
| |
| mouse |
melanoma
|
melanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
| B16 melanoma |
JCRB0202
| more |
|
|
mouse |
Page Top
| | | | |
| neural | |
| |
| |
| mouse |
neural
|
astrocyte line, GFAP-positive, (C3H/He mouse)
| KT-5 |
IFO50161
| more |
|
| mouse |
neural
|
astrocyte-progenitor cell line, (C3H/He mouse)
| AP-16 |
IFO50424
| more |
|
| mouse |
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
| MEB 5 |
JCRB0145
| more |
|
| mouse |
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
| MEB5 |
IFO50472
| more |
|
| mouse |
neural
|
derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
| A1 |
IFO50519
| more |
|
| mouse |
neural
|
microglial cell line, p53-deficient. Requires A1 conditioned medium for culture.
| MG5 |
IFO50520
| more |
|
| mouse |
neural
|
neuroblastoma, (A albino mouse)
| Neuro-2a |
IFO50081
| more |
|
| mouse |
neural
|
neuroblastoma, 6-thioguanine-resistant,HAT-sensitive, (A albino mouse)
| Neuro-2aTG |
IFO50495
| more |
|
| mouse |
neural
|
normal mixed glial culture, (C3H/He mouse)
| MA-89 |
IFO50293
| more |
|
|
mouse |
Page Top
| | | | |
| olfactory epithelium | |
| |
| |
| mouse |
olfactory epithelium
|
dark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
| DBC1.2 |
IFO50484
| more |
|
|
mouse |
Page Top
| | | | |
| ovary | |
| |
| |
| mouse |
ovary
|
ovarian granulosa cell tumor, non-metastatic
| OV3121 |
JCRB1026
| more |
|
| mouse |
ovary
|
ovarian surface epithelial cell line from p53(-/-) mouse
| p53-def-MOSE |
JCRB0151.1
| more |
|
| mouse |
ovary
|
ovarian surface epithelial cell line immortalized by SV40 large T antigen, (C3H/He mouse)
| T-Ag-MOSE |
JCRB0151
| more |
|
| mouse |
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, highly metastatic, ((C57BL/6N x C3H/He) F1 mouse)
| OV3121-ras4 |
JCRB0186
| more |
|
| mouse |
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, moderately metastatic, ((C57BL/6N x C3H/He) F1 mouse)
| OV3121-ras7 |
JCRB0187
| more |
|
|
mouse |
Page Top
| | | | |
| pituitary | |
| |
| |
| mouse |
pituitary
|
pituitary tumor, ACTH producing, (LAF1 mouse)
| AtT-20 |
JCRB9098
| more |
|
|
mouse |
Page Top
| | | | |
| sarcoma | |
| |
| |
| mouse |
sarcoma
|
chondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
| EHS |
IFO50268
| more |
|
| mouse |
sarcoma
|
S-180 sarcoma derivative
| CCRF S-180 II |
JCRB9089
| more |
|
|
mouse |
Page Top
| | | | |
| skin | |
| |
| |
| mouse |
skin
|
3T3-like near-diploid, derived from embryonic skin (ICR/Jcl mouse)
| m5S |
JCRB1322
| more |
|
| mouse |
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
| I51T |
JCRB1225
| more |
|
| mouse |
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
| R201C |
JCRB1199
| more |
|
| mouse |
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
| NCTC Clone 929 |
JCRB9003
| more |
|
| mouse |
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
| NCTC clone 929 |
IFO50409
| more |
|
| mouse |
skin
|
fibroblast, thymidine kinase-deficient, (C3H mouse)
| L cl 1D |
JCRB0722
| more |
|
| mouse |
skin
|
human beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
| GP8 |
JCRB1198
| more |
|
| mouse |
skin
|
L cell derived, can grow in a serum-free medium, (C3H mouse)
| L.P3(S) |
JCRB0605
| more |
|
| mouse |
skin
|
L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
| L alpha |
JCRB0125
| more |
|
| mouse |
skin
|
serum-free adapted L929 cell line
| L.P3 |
JCRB0648
| more |
|
| mouse |
skin
|
skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
| A9 |
JCRB0211
| more |
|
| mouse |
skin
|
skin fibroblast, bromodeoxyuridine-resistant
| B82 |
JCRB0212
| more |
|
| mouse |
skin
|
SV40-immortalized fibroblast line from beta-galactosidase-deficient mouse
| SV |
JCRB1207
| more |
|
|
mouse |
Page Top
| | | | |
| spleen | |
| |
| |
| mouse |
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
| MSS31 |
IFO50375
| more |
|
| mouse |
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
| MSS62 |
IFO50376
| more |
|
|
mouse |
Page Top
| | | | |
| teratoma | |
| |
| |
| mouse |
teratoma
|
teratocarcinoma, (129/Sv mouse)
| OTT6050 |
JCRB0720
| more |
|
| mouse |
teratoma
|
teratocarcinoma, (129/Sv mouse)
| PCC4 |
JCRB0205
| more |
*1) |
| mouse |
teratoma
|
teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse)
| PCC4 AG Cap |
JCRB0216
| more |
|
| mouse |
teratoma
|
teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse)
| PCC4 AG |
JCRB0206
| more |
|
| mouse |
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
| F9 |
JCRB0721
| more |
|
| mouse |
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
| F9-41 |
JCRB0001
| more |
|
|
mouse |
Page Top
| | | | |
| testis | |
| |
| |
| mouse |
testis
|
Leydig cell testicular tumor (BALB/cJ mouse)
| I-10 |
JCRB9097
| more |
|
| mouse |
testis
|
Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
| B-1 |
JCRB0243
| more |
|
|
mouse |
Page Top
| | | | |
| thymidylate defective | |
| |
| |
| mouse |
thymidylate defective
|
complete defective strain of thymidylate synthase, (C3H mouse)
| FSthy21 |
JCRB0719
| more |
|
|
mouse |
Page Top
| | | | |
| thymus | |
| |
| |
| mouse |
thymus
|
thymic nurse cell, (BALB/c mouse)
| IT-79MTNC3 |
IFO50248
| more |
|
|
mouse |
Page Top
| | | | |
| vascular system | |
| |
| |
| mouse |
vascular system
|
aortic smooth muscle cell line from p53 knockout mouse
| P53LMACO1 |
JCRB0150
| more |
|
| mouse |
vascular system
|
endothelial cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
| TKD2 |
IFO50374
| more |
|
|
pig |
Page Top
| | | | |
| kidney | |
| |
| |
| pig |
kidney
|
kidney
| PK(15) |
JCRB9040
| more |
|
| pig |
kidney
|
susceptible to rubella, vaccinia and herpes viruses
| LLC-PK1 |
JCRB0060
| more |
|
| pig |
kidney
|
susceptible to Vaccinia virus
| PKF |
IFO50422
| more |
|
| pig |
kidney
|
susceptible to Vaccinia virus
| PKR |
IFO50423
| more |
|
| pig |
kidney
|
susceptible to Vaccinia virus
| PKS |
IFO50421
| more |
|
|
pygmy mouse |
Page Top
| | | | |
| tail | |
| |
| |
| pygmy mouse |
tail
|
normal, support the growth of all 4 classes of MuLV
| M.dunni(Clone III8C) |
JCRB9124
| more |
|
|
rabbit |
Page Top
| | | | |
| cornea | |
| |
| |
| rabbit |
cornea
|
cornea, (white rabbit)
| RC-1 |
JCRB0246
| more |
|
| rabbit |
cornea
|
susceptible to rubella virus
| SIRC |
IFO50020
| more |
|
| rabbit |
cornea
|
susceptible to rubella virus
| SIRC |
JCRB9122
| more |
|
|
rabbit |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| rabbit |
hemo-lymphocytic
|
Rabbit lymphocyte cell line transformed with HTLV-I. HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
| Ra-1 |
JCRB1313
| more |
*2) |
|
rabbit |
Page Top
| | | | |
| kidney | |
| |
| |
| rabbit |
kidney
|
an aneuploid cell line, (New Zealand white rabbit)
| LLC-RK1 |
JCRB9034
| more |
|
|
rabbit |
Page Top
| | | | |
| lung | |
| |
| |
| rabbit |
lung
|
HSV,VSV sensitive, suitable for study anti-viral agents
| RL-33 |
JCRB0131
| more |
|
|
rat |
Page Top
| | | | |
| ***** | |
| |
| |
| rat |
*****
|
*****
| YSK |
JCRB0619
| more |
*1) |
|
rat |
Page Top
| | | | |
| colon | |
| |
| |
| rat |
colon
|
DMH induced colonic cancer, (F344/DuCrj rat)
| RCN-9 |
JCRB0167
| more |
|
|
rat |
Page Top
| | | | |
| embryo | |
| |
| |
| rat |
embryo
|
3Y1 derivative, Ad12-transformed, (Fischer rat)
| Ad12-3Y1-Z19 |
JCRB0737
| more |
|
| rat |
embryo
|
3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat)
| Py-3Y1-S2 |
JCRB0736
| more |
|
| rat |
embryo
|
3Y1 derivative, SV40-transformed, (Fischer rat)
| SV-3Y1-C66 |
JCRB0735
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
| E1A-3Y1-1 |
JCRB0738
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
| NG-3Y1-T15L |
JCRB0739
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
| NG-3Y1-T308 |
JCRB0740
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
| NG-3Y1-T6R |
JCRB0741
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat)
| SR-3Y1-2 |
JCRB0742
| more |
|
| rat |
embryo
|
3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
| HR-3Y1-2 |
JCRB0743
| more |
|
| rat |
embryo
|
3Y1-derivative, ts mutant cell line with cell cycle arrest at G0 phase, (Fischer rat)
| tsJT60 |
JCRB0153.3
| more |
|
| rat |
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G0 and G1 to S phase, (Fischer rat)
| tsJT16 |
JCRB0153.2
| more |
|
| rat |
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G1 to S phase, (Fischer rat)
| tsJT663 |
JCRB0153.1
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-14 |
JCRB0143.5
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-16 |
JCRB0143.2
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-18 |
JCRB0143.3
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-23 |
JCRB0143.6
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-24 |
JCRB0143.4
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-28 |
JCRB0143.7
| more |
|
| rat |
embryo
|
EBNA2-transfected, (Fischer rat)
| F2408 EBNA2 cl-9 |
JCRB0143.1
| more |
|
| rat |
embryo
|
fibroblast transformed by c-Ha-ras oncogene
| 5RP7 |
IFO50277
| more |
|
| rat |
embryo
|
fibroblast, whole embryo, (Fischer 344 rat)
| 3Y1-B Clone 1-6 |
JCRB0734
| more |
|
| rat |
embryo
|
fibroblast-like, (Fischer rat)
| F2408 |
IFO50015
| more |
|
| rat |
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
| F2408-B812 |
IFO50099
| more |
|
| rat |
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
| F2408-B993 |
IFO50100
| more |
|
| rat |
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
| F2408-No.3 |
IFO50098
| more |
|
| rat |
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
| F2408-No.7 |
IFO50102
| more |
|
| rat |
embryo
|
pZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
| F2408 pZipNeo |
JCRB0143.0
| more |
|
| rat |
embryo
|
thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat)
| RAT-2 |
IFO50282
| more |
|
| rat |
embryo
|
thymidine kinase-deficient F2408 cell line, (Fischer rat)
| F2408-No.20 |
IFO50101
| more |
|
|
rat |
Page Top
| | | | |
| hemo-lymphocytic | |
| |
| |
| rat |
hemo-lymphocytic
|
granurocytic sarcoma, (Wister rat)
| Shay |
JCRB0241
| more |
|
| rat |
hemo-lymphocytic
|
leukemia, basophilic (Wister rat)
| RBL-1 |
IFO50034
| more |
|
| rat |
hemo-lymphocytic
|
leukemia, basophlic, mast cell line (Wistar rat)
| RBL-2H3 |
JCRB0023
| more |
|
| rat |
hemo-lymphocytic
|
myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat)
| Y3-Ag 1.2.3 |
JCRB9091
| more |
|
| rat |
hemo-lymphocytic
|
RLV infected myelomonocytic leukemia.
| c-WRT-7-LR |
JCRB0168
| more |
|
|
rat |
Page Top
| | | | |
| kidney | |
| |
| |
| rat |
kidney
|
epithelioid clone of NRK (normal rat kidney) cells, (Osbone-Mendel rat)
| NRK-52E |
IFO50480
| more |
|
| rat |
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
| NRK-49F |
IFO50481
| more |
|
| rat |
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
| NRK-49F |
JCRB9067
| more |
|
| rat |
kidney
|
transformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
| 77N1 |
IFO50280
| more |
|
|
rat |
Page Top
| | | | |
| liver | |
| |
| |
| rat |
liver
|
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
| Ac2F(DT) |
JCRB0416
| more |
|
| rat |
liver
|
Ac2F-derived, spontaneously transformed, (Donryu rat)
| Ac2F(ST) |
JCRB0417
| more |
|
| rat |
liver
|
ascites hepatoma, (Donryu rat)
| AH66tc |
JCRB0411
| more |
|
| rat |
liver
|
ascites hepatoma, (Donryu rat)
| AH70Btc |
JCRB0412
| more |
|
| rat |
liver
|
ascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
| AH-7974.P3 |
JCRB0714.1
| more |
|
| rat |
liver
|
ascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
| JTC-16 P3 |
JCRB0714
| more |
|
| rat |
liver
|
DAB transformed liver cell line, (JAR rat)
| M |
JCRB0152.1
| more |
|
| rat |
liver
|
DAB transformed liver cell line, protein and lipid-free culture, (JAR rat)
| M.P3 |
JCRB0152.2
| more |
|
| rat |
liver
|
DAB transformed liver cell line, protein and lipid-free culture, deposited directly by original developer (JAR rat)
| M.P3 |
JCRB0152.3
| more |
|
| rat |
liver
|
hepatic stellate cell line immortalized with SV40 T antigen, [mycoplasma-positive] (Wistar rat)
| RI-T |
JCRB1088
| more |
|
| rat |
liver
|
hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
| FAA-HTC1 |
JCRB0249
| more |
|
| rat |
liver
|
hepatoma, (Donryu rat)
| 3'-mRLh-2 |
JCRB0431
| more |
|
| rat |
liver
|
hepatoma, (Donryu rat)
| dRLh-84 |
JCRB0410
| more |
|
| rat |
liver
|
hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
| FF101 |
JCRB1040
| more |
|
| rat |
liver
|
liver adenoma, (Donryu rat)
| dRLa-74 Clone 2 |
JCRB0409
| more |
|
| rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
| 3'-mRLN-30 |
JCRB0421
| more |
|
| rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
| 3'-mRLN-31 |
JCRB0422
| more |
|
| rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
| dRLN-4 |
JCRB0418
| more |
|
| rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
| dRLN-6 |
JCRB0420
| more |
|
| rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
| dRLN-9 |
JCRB0419
| more |
|
| rat |
liver
|
liver epithelial cell line, reported as oval cell-like, (Fischer F344 rat)
| WB-F344 |
JCRB0193
| more |
|
| rat |
liver
|
liver epithelial cell, (F344/DuCrj rat)
| ARLJ301-3 |
JCRB0248
| more |
|
| rat |
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
| BRL-3A |
JCRB9114
| more |
|
| rat |
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
| BRL-3A |
JCRB0025
| more |
|
| rat |
liver
|
non-transformed live cell line, (BD-IV rat)
| IAR-20 |
JCRB0610
| more |
|
| rat |
liver
|
normal liver, (Donryu rat)
| RLN-10 |
JCRB0415
| more |
|
| rat |
liver
|
normal liver, (Donryu rat)
| RLN-8 |
JCRB0414
| more |
|
| rat |
liver
|
normal liver, (Donryu rat)
| RLN-B2 |
JCRB0402
| more |
|
| rat |
liver
|
normal liver, (Donryu rat)
| RLN-J-5-2 |
JCRB0407
| more |
|
| rat |
liver
|
normal liver, diploid, (Donryu rat)
| Ac2F |
JCRB0408
| more |
|
| rat |
liver
|
normal liver, RLC-10 derivative, no serum required, (JAR-1 rat)
| RLC-10.P3 |
JCRB0718
| more |
|
| rat |
liver
|
normal liver, RLC-10 derivative, no serum required, deposited directly by original developer (JAR-1 rat)
| RLC-10.P3 |
JCRB0718.1
| more |
|
| rat |
liver
|
normal, collagen-induced growth arrest, (Wistar rat)
| RL-34 |
JCRB0247
| more |
|
| rat |
liver
|
transplantable ascites hepatoma, (Donryu rat)
| AH601(JTC27) |
JCRB0132.1
| more |
|
| rat |
liver
|
transplantable ascites hepatoma, serum-free, (Donryu rat)
| AH601.P3(JTC27) |
JCRB0132.2
| more |
|
| rat |
liver
|
transplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
| AH601.P3(JTC27) |
JCRB0132.3
| more |
|
|
rat |
Page Top
| | | | |
| lung | |
| |
| |
| rat |
lung
|
adult lung
| L-2 |
JCRB9053
| more |
|
| rat |
lung
|
immortal cell line from MNNG-transformed tracheal epithelial cells
| EGV-4T |
JCRB0229
| more |
|
| rat |
lung
|
lung, (JAR-1 rat)
| JTC19 |
JCRB0608
| more |
|
|
rat |
Page Top
| | | | |
| lymph node | |
| |
| |
| rat |
lymph node
|
sticky cell from lymph node, serum-free, (JAR-2 rat)
| LYM-1.P3 |
JCRB0144.1
| more |
|
| rat |
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
| LYM-1.P3B |
JCRB0144.1B
| more |
|
| rat |
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
| LYM-1.P3D |
JCRB0144.1D
| more |
|
|
rat |
Page Top
| | | | |
| mammary | |
| |
| |
| rat |
mammary
|
mammary carcinoma, dimethylbenzathracene induced, (SD rat)
| RMT-1 E4 |
JCRB0242
| more |
|
| rat |
mammary
|
mammary myoepithelial cell, dimethylbenzathracene induced, (SD rat)
| RMT-1 M2 |
JCRB0245
| more |
|
|
rat |
Page Top
| | | | |
| muscular system | |
| |
| |
| rat |
muscular system
|
skeletal muscle myoblast
| L6 |
IFO50364
| more |
|
| rat |
muscular system
|
skeletal muscle myoblast
| L6 |
JCRB9081
| more |
|
| rat |
muscular system
|
skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant
| L6TG Cap |
JCRB0210
| more |
|
| rat |
muscular system
|
skeletal muscle myoblast, 6-thioguanine-resistant
| L6TG |
JCRB0209
| more |
|
|
rat |
Page Top
| | | | |
| neural | |
| |
| |
| rat |
neural
|
astrocyte, GFAP-positive, (Wistar rat)
| RNB |
IFO50491
| more |
|
| rat |
neural
|
astrocyte-like cells, GFAP-positive
| RCR-1 |
JCRB0129.1
| more |
|
| rat |
neural
|
astrocyte-like cells, GFAP-positive, serum-free
| RCR-1.P3 |
JCRB0129.0
| more |
|
| rat |
neural
|
C6 subline adapted to serum-free medium
| C6-SF2 |
IFO50425
| more |
|
| rat |
neural
|
glial tumor, GFAP-positive
| C6 |
IFO50110
| more |
|
| rat |
neural
|
glial tumor, GFAP-positive
| C6 |
JCRB9096
| more |
|
| rat |
neural
|
human MDM2 protein-expressing astrocyte cell line, (Wistar rat)
| MDM2-RNB |
IFO50490
| more |
|
| rat |
neural
|
PC-12 derivative adapted to serum-free culture
| PC-12.P3 |
JCRB0130
| more |
|
| rat |
neural
|
PC-12 derivative adapted to serum-free culture, direct deposition by original developer
| PC-12.P3 |
JCRB0130.1
| more |
|
| rat |
neural
|
pheochromocytoma, , neuronal differentiation by NGF, adhesive variant
| PC-12 |
JCRB0733
| more |
|
| rat |
neural
|
pheochromocytoma, highly NGF-sensitive clone of PC-12
| PC12HS |
JCRB0266
| more |
|
| rat |
neural
|
pheochromocytoma, moderately NGF-sensitive clone of PC-12
| PC12MS |
JCRB0267
| more |
|
| rat |
neural
|
pheochromocytoma, neuronal differentiation by NGF, 6-thioguanine-resistant,HAT-sensitive
| PC-12TG |
IFO50496
| more |
|
| rat |
neural
|
pheochromocytoma, neuronal differentiation by NGF, grow in suspension
| PC-12 |
IFO50278
| more |
|
| rat |
neural
|
pheochromocytoma, NGF-insensitive clone of PC-12
| PC12IS |
JCRB0268
| more |
|
| rat |
neural
|
pheochromocytoma, serum-free adapted PC12 HS
| PC12HS.P3 |
JCRB0263.1
| more |
|
|
rat |
Page Top
| | | | |
| pituitary | |
| |
| |
| rat |
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
| GH3 |
IFO50105
| more |
|
| rat |
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
| GH3 |
JCRB9047
| more |
|
| rat |
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
| GH1 |
JCRB9046
| more |
|
| rat |
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
| GH1 |
IFO50269
| more |
|
|
rat |
Page Top
| | | | |
| sarcoma | |
| |
| |
| rat |
sarcoma
|
fibrosarcoma, methylcholantheren-induced, highly tumorigenic, (Donryu rat)
| MS-653-A |
JCRB1001.1
| more |
|
| rat |
sarcoma
|
fibrosarcoma, methylcholantheren-induced, less tumorigenic, (Donryu rat)
| MS-653-G |
JCRB1001.2
| more |
|
| rat |
sarcoma
|
osteosarcoma, 32P-induced, (F344 rat)
| MSK |
JCRB0259
| more |
|
| rat |
sarcoma
|
RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat)
| XC |
IFO50017
| more |
|
|
rat |
Page Top
| | | | |
| skin | |
| |
| |
| rat |
skin
|
epidermal keratinocyte line from fetal skin
| FRSK |
JCRB0005
| more |
|
|
rat |
Page Top
| | | | |
| spleen | |
| |
| |
| rat |
spleen
|
spleen, spontaneously transformed cells, (Donryu rat)
| RS-A |
JCRB0423
| more |
|
|
rat |
Page Top
| | | | |
| squamous cell carcinoma | |
| |
| |
| rat |
squamous cell carcinoma
|
squamous cell carcinoma
| SCC-131 |
JCRB0230
| more |
|
| rat |
squamous cell carcinoma
|
squamous cell carcinoma
| SCC-158 |
JCRB0231
| more |
|
|
rat |
Page Top
| | | | |
| submandibular gland | |
| |
| |
| rat |
submandibular gland
|
submandibular gland-derived epithelial cell line, (Wistar rat)
| RSMG-1 |
JCRB1146
| more |
|
|
rat |
Page Top
| | | | |
| testis | |
| |
| |
| rat |
testis
|
Leydig cell testicular tumor
| LC540 |
JCRB9064
| more |
|
| rat |
testis
|
Leydig cell testicular tumor,steroid secreting
| R2C |
JCRB9055
| more |
|
|
rat |
Page Top
| | | | |
| thymus | |
| |
| |
| rat |
thymus
|
T cell differentiation factor producing, (Wistar rat)
| IT-26R21 |
IFO50078
| more |
|
| rat |
thymus
|
T cell differentiation factor producing, (Wistar rat)
| IT-45R1 |
IFO50076
| more |
|
| rat |
thymus
|
thymic fibroblast, (Wistar rat)
| IT-45R91 |
IFO50077
| more |
|
| rat |
thymus
|
thymic stroma, keratin-positive, (ACI rat)
| TuD-1 |
IFO50103
| more |
|
| rat |
thymus
|
thymic stroma, keratin-positive, (ACI rat)
| TuD-1-3 |
IFO50152
| more |
|
| rat |
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
| TaD-1 |
IFO50112
| more |
|
| rat |
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
| TaD-1-3 |
IFO50120
| more |
|
|
rat |
Page Top
| | | | |
| thyroid | |
| |
| |
| rat |
thyroid
|
medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
| 6-23 clone 6 |
IFO50270
| more |
|
|
tupaia |
Page Top
| | | | |
| lung | |
| |
| |
| tupaia |
lung
|
normal, applicable for the mutation assay system in vitro
| T-23 clone 8 |
JCRB0745
| more |
|